(Medicines) Complete

THE PUNJAB EMPLOYEES' SOCIAL SECURITY INSTITUTION
(HEAD OFFICE)
3/A, Gulberg-V, Lahore.
Tender NO.SSP(510)/2015/Vol-VI/
TENDER FEE:
Rs. 1000/- (Non-refundable)
LAST DATE OF RECEIPT:
30.03.2015 ( 10.30 A.M.)
DATE OF OPENING:
30.03.2015 ( 11.00 A.M.)
SUBJECT:-
PURCHASE OF MEDICINES, INJECTION INTERFERON AND DISPOSABLE

SYRINGES FOR THE YEAR 2015-16
Technical specifications for the purchase of medicines for the year 2015-16 are
enclosed herewith.
Instructions to the bidders, General Conditions of contract, special
conditions of Contract & schedule of requirements are detailed in the bidding
document available at PPRA Web Site www.ppra.punjab.gov.pk and PESSI website
www.pessi.gop.pk.
NO.SSP (510)/2015/Vol-VI/
Dated
Lahore, the
2015
M/s. ____________________
________________________
________________________
DIRECTOR (PURCHASE)
This is certified that the item quoted against PESSI No. _________________with
brand name of _____________________________is readily available at the head offices of
following leading chain pharmacies of Lahore city.
S.#.
NAME OF PHARMACY
1.
Fazal Din Pharma Plus.
2.
Green Plus
3.
Clinix
4.
Servaid.
VERIFIED BY THE AUTHORIZED

OFFICER/OFFICIAL OF HEAD OFFICE OF
RESPECTIVE PHARMACY WITH NAME,
DESIGNATION & STAMP.
Last one year bill warranties duly verified from the Head Offices of the
Pharmacies of the quoted items should be attached (Mandatory).
I Mr/Miss________________________________________________________________________
Designation __________________________________________on the behalf of my firm hereby
undertake that if above said information is left unattended or proved to be wrong on checking,
the department reserves the right to reject the offer which is not challengeable in any court of
law.
Signature of Authorized Person.
_______________________________________
Name of Authorized Person:
_______________________________________
Designation of Authorized Person:
_______________________________________
Participating Firm Name:
_______________________________________
Phone No.
_______________________________________
Stamp:
_______________________________________
PRICE SCHEDULE.
Must be attached (duly signed and stamped) with Financial Bid.
Tender No._______________Due on ___________
Manufactured by __________________
Address.________________
Manufacturing license No. __________Validity _________
ITE
M #.
PES
SI #
NAM
E AS
IN
PESS
I LIST
BRAND
NAME
OF THE
OFFER
ED
ITEM
QTY.
REQ
UIRE
D
DRUG
REGD
. NO.
PACKIN
G
OFFER
ED
MRP
FIXED
BY
F.G.
T.P.
OF
THE
DRU
G
MARKE
T
AVERA
GE T.P.
PRICE
OFFERED
In
figure
s
In
words.
VALUE
Signature of Authorized Person. ____________________________________________

_______________________________________
Designation of Authorized Person:
_______________________________________
Participating Firm Name:
_______________________________________
Phone No.
_______________________________________
Stamp:
_______________________________________
EVALUATION CRITERIA FOR GENERAL MEDICINES 2015-16

1
ii.
Physical report
Complies with Official Books (BP/USP etc)/Complies
manufacturers Spec
Quality of Printing, Packing / Packaging & Labeling Material
iii.
Submission of complete Drug Specification proforma
02
Length of registration of relevant product from Ministry of

Health.
10
i.
1 10 years (1 mark for each year)
Past Performance of bidder with PESSI. (Last 2 years)

Execution of Supply Order 100%
Execution of Supply Order more than 50% and less than 100%
20
10
10
Compliance to Supply Order from PESSI outlets
10

Financial Position/status.
Income Tax return/any other proof of Income Tax paid for last two
years.
Financial Bank soundness certificate up to 10 million.
10
10
05
Market availability of the quoted item at Head Offices of Leading

Chain Pharmacies for last one year (Fazal Din, Servaid, Clinix
and Green Plus).
Availability of quoted item at two Pharmacies
25
ii.
Availability of quoted item at three Pharmacies
20
iii.
Availability of quoted item at Four Pharmacies
25
Percentage of dosage forms approved by prequalification team.
10
i.
Less than 50%
03
ii.
More than 50% / Less than 100%
05
Iii
7
100%
Quality Certificates.
ISO certification of SOPs
10
10
02
GMP Certification issued by Ministry of Health.
08
i.
i.
ii.
i.
ii.
5
i.
i.
ii.
with
15
03
10
1-10
5
8
Total:-
02
05
15
100
Anticancer Medicines shall be evaluated under Clause-5 as per following

details:CLAUSE-5 FOR ANTICANCER MEDICINES.
5.
(i)
(ii)
(iii)
Market availability at pharmacies of Shaukat 25

Khanum, Inmol, Mayo Hospital and Jinnah Hospital
for last one year.
Availability of medicines at 02 pharmacies
15
20
25
Following Clause-5 shall also be applicable for Hospital Items (Anaesthesia

medicines, Dressing, POP, Cotton Wool, Cotton Gauze, Cotton and Crepe
Bandage):CLAUSE-5 FOR HOSPITAL ITEMS
Anesthesia items, Dressing, Gauze, Cotton Wool, Bandages, Dressing and POP.
5.
(i)
(ii)
(iii)
Supply order from Government Institutions (last one

year)
02 Government Institutions
25
15
20
25
The firms having no past experience with PESSI Head Office shall be
evaluated under clause-3 as per following detail:CLAUSE-3 FOR THE FIRMS HAVING NO PAST EXPERIENCE WITH PESSI
HEAD OFFICE
3.
Past Performance of bidder with Government 20
Institutions and PESSI local tender. (Last 2 years)
(i)
Supply
order
of
Government
Hospitals 05
(1-5 Institutions)
Supply
order
of
Government
Hospitals 10
(More than 5 Institutions)
(ii)
Supply orders of Private Hospital / Organization (1-5 05
Supply Orders)
Supply orders of Private Hospital / Organization (More 10
than 5 Supply Orders)
Note:
1. Any medicine having adverse reaction / poor efficacy reported by the
consultants shall be straightway disqualified and shall not be further evaluated
under the Evaluation Criteria.
2. Minimum qualifying marks 70/100.
3. Medicines qualifying 70% marks shall be presented before the Technical
Committee comprising of Specialists of PESSI Hospitals for their reservation
regarding the efficacy of any medicines keeping in view their past experience
and decision of the committee regarding qualification / disqualification shall
prevail.
Instructions
1. Requisite documents to be enclosed with the technical offer should have proper
page marking.
2. Invoices / Bill Warranties of respective pharmacies should have page marking
and same should be mentioned in Drug Specification Proforma in the relevant
column.
EVALUATION CRITERIA FOR INTERFERON 2015-16
i.
ii.
Physical report.
manufacturers Spec
with
Length of registration of relevant product from Ministry of Health.
i.

i.
ii.
i.
ii.
5
i.
ii.
iii.
6
i.
ii.
7
i.
ii.
8
i.
ii.
10
05
05
10
1-10
20
10
5

10
10
10
Detail of supply in public/private organizations (last one year)

Public organizations.
15
More than Five.
15
05
Private organizations.
15
More than Five.
Market availability of the quoted item at Head Office of Leading
and Green Plus)
05
25
10
05
10
10
05
05
10
02
08
100
08
07
25
15
20
Packing of the quoted item.

Ampoule/Vial
Pre-filled Syringe.
Product Certification.
WHO/FDA approved.
Dose and efficacy certificate from NIH Islamabad.
Total:Note:
1. Medicines having adverse reaction / poor efficacy reported by the consultants
shall be straightway disqualified and shall not be further evaluated under the
Evaluation Criteria.
regarding the efficacy of any medicines keeping in view their past experience and
decision of the committee regarding qualification / disqualification shall prevail.
Instructions
page marking.

column.
EVALUATION CRITERIA FOR DISPOSABLE SYRINGES 2015-16
Mandatory Clauses:Product should be registered with M.O.H / DRAP.
In case of imported syringes, the product must be available in the country of
origin and provide Sole Agency Agreement with foreign manufacturer duly
attested by the concerned Pakistan Embassy / High Commission.
Firms should have following certificates
(i)
ISO 13485, ISO 9001
(ii)
CE Mark
(iii)
GMP Certificate (last one year).
1.
2.
3.
General Clauses
1
Physical report
i. Quality of Printing, Packing / Packaging & Labeling Material

ii. Raw Material used is of Medical Grade attach proof/under taking.
iii. Submission of complete Drug Specification proforma.
2
Physical Examination of Syringe by Technical Committee.
i.
ii.
3
i.
ii.
4
i.
ii.
5
i.
ii.
iii.
Sharpness of needle.
Plunger positive/negative pressure.
Financial position/status.
Income Tax Return/any other Proof of Income Tax paid for last one
year.
Financial Bank soundness certificate upto 10 million.
15
More than Five.
25
10
10
05
25
13
12
10
05
03
05
15
05
08
05
15
More than Five.
07
Market Availability of the quoted items at Head Office of Leading
25
and Green Plus)
15
20
25
Total:100
Note:
i.
Minimum qualifying marks 70/100.
ii.
Medicines qualifying 70% marks shall be presented before the
Technical Committee comprising of Specialists of PESSI Hospitals

for their reservation regarding the efficacy of any medicines
keeping in view their past experience and decision of the
committee regarding qualification / disqualification shall prevail.
Instructions
page marking.
column.
Bid Reference No:
Check List (Mandatory) for Documentary Evidence

S. #
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Required
Documentation
Original Tender
Purchase Receipt (F-6)
Drug Specification
proforma duly completed
Copy of valid Drug
Registration Certificates
Copies of Bill Warranty
for the last one year duly
verified by head offices
of leading chain
pharmacies as mentioned
in Bidding Documents.
Copies of supply order of
hospital items
Requisite supply order
for firms having no past
experience with PESSI
Head Office under
Clause-3
Copy of Valid
Manufacturing License
Copy of Valid Drugs
Sale License
Letter of Authorization
from manufacturers /
Sole Agency Agreement
Proof of availability of
the disposable syringes
in the country of origin
Proof of raw material
used is of medical grade
(in case of disposable
syringes)
Copy of NTN Certificate
Copy of Income Tax
Return for the last two
years
Copy of Financial
Banks Soundness
Certificate
Copy of General Sales
Tax Registration
Copy of valid ISO and
other certification
Copy of valid GMP and
other Certificate
Copy of valid prequalification with PESSI
Affidavit on Stamp
Paper worth Rs. 100/-
20.
Latest price list
21.
Samples in Commercial
Packs
Checklist
(To be initialed
by the Bidder
against each
document)
Relevant
Page
Number in
the Bid
Supporting Documents
(To be filled by the Bidder with name of
the documents that are submitted to meet
the requirement)
The Commissioner,
Punjab Employees Social Security Institution,
3-A, Gulberg-V,
Lahore.
Dated:
(Ref. Tender No
AFFIDAVIT
1.
I/We, the undersigned solemnly state that:

a. We have read the contents of the Bidding Documents and have fully
understood and the same are acceptable.
b. The Bid being submitted by the undersigned complies with the requirements
enunciated in the bidding documents.
2.
We hereby undertake that our firm is not blacklisted on any ground by PESSI,
any Government (Federal/Provincial/District), a local body or Public Sector
Organization under ITB Clause No:14 (iii) (c)
3.
We hereby undertake that the prices quoted to PESSI are not more than the
prices quoted to Health Department Government of the Punjab or any other
Organization during the reference financial year mentioned in the tender and
are not more than the trade prices under GCC Clause No.1(C).
4.
We hereby undertake that we will be responsible for the free provision of new
stores if the same are found to be substandard or at variance with the
specifications given in the tender enquiry under SCC Clause No.6.
Name
Designation
Name of Firm
Stamp
THE PUNJAB EMPLOYEES' SOCIAL SECURITY INSTITUTION

(HEAD OFFICE)
SPECIFICATIONS OF MEDICINES YEAR 2015-16
S.#
NEW
ITEMS
PESSI #
(A)
P-0001
Pack Size
ANTACIDS:
Susp. Alu Hydroxide 215mg, Mag. Hydroxide

80mg, Simethicone 25mg/5ml
P-0002
Tab Ranitidine. 150mg.
P-0003
Inj. Ranitidine 50mg/2ml.
P-0004
Susp.Sucralfate 1gm/5ml
P-0005
Cap.Omeprazole 20mg Pellets
P-0006
Tab. Mag. Trisilicate 500mg + Dried Alu

Hydroxide250mg.
Infusion Omeprazole Sodium 42.6mg equivalent
to Omeprazole 40mg.
7
8
P-0007
P-0008
Tab. Famotidine
Tab. Famotidine
P-0009
Qty
120ml
190900
20
65284
39622
60ml
800
14
195692
100
11300
100ml
40300
20
37200
10
21200
20mg
40mg
Tab.Sodamint (Sodium Bicarbonate).
1000
(B)
40
ANTISPASMODIC/ANTICHOLINERGIC:
0
10
11
12
13
14
15
16
P-0010
Inj. Atropine Sulphate 1mg/ml (1ml Amp).
P-0011
Tab. / Cap. Mebevirine 135mg.
P-0012
Tab. Mesalazine 400mg.
P-0013
Inj.Neostigmine 2.5mg/5ml
P-0014
Tab.Pyridostigmine Bromide 60mg
P-0015
Tab. Chlordiazepoxide 5mg + Clidinium Bromide 2.5mg.
P-0016
Tab.Hydrated Phloroglucinol 80mg eqivalent to anhydrous

Phloroglucinol 62.233mg, trimethylphloroglucinol 80mg
100
755
30
2124
30
904
Amp
270
20
30
30
3800
17
18
19
20
P-0017
Tab.Hyoscine-N-butylbromide10mg,Paracetamol500mg.
P-0018
Inj.Hydrated Phloroglucinol 40mg,trimethylphloroglucinol

0.04mg
P-0019
P-0020
100
9214
2950
30
712
10
Inj.Hyoscine-N-butyl bromide 20mg/1ml
Inj.Glycopyrrolate 0.2mg/ml
( C )
ANTI-DIARRHOEALS:
0
P-0021
Tab. Attapulgite 500mg
P-0022
Susp. Furazolidone 25mg / 5ml, Kaolin Pectin
23
P-0023
O.R.S. Sachet contains:NaCl 3.5gm, Sod.Citrate 2.9gm,

KCL1.5gm, Dextrose Anhydrous 20gm.
24
P-0024
Dioctahedral Smectite 3gm Powder.
P-0025
Saccharomyces Boulardil 250mg Powder
P-0026
Tab. Diphenoxylate HCL 2.5mg + Atropine Sulphate 25mcg.
21
22
25
26
27
28
P-0027
Susp. Activated Attapulgite 1000mg/10ml.
P-0028
Susp.Zinc Sulphate Monohydrate 10mg equivalent to 3.64mg

Elemental Zinc
(D)
100
2811
120ml
13625
30gm
42100
30
3795
10
110
500
50
60ml
4000
60ml
7300
ANTI-AMOEBICS:
200
29
P-0029
Tab.Metronidazole 200mg
200
1600
100
18030
Vial
136600
90ml
41000
60ml
26150
Tab.Metronidazole 400mg
30
P-0030
Inj. Metronidazole 500mg/100ml.
31
P-0031
Susp. Metronidazole 200mg/5ml.
P-0032
Susp. Metronidazole 75mg+ Furazolidine 25mg.
P-0033
Tab. Diloxanide Furoate 500mg + Metronidazole 400mg.
P-0034
Syp. Diloxanide Furoate 250mg+Metronidazole Benzoate

320mg equivalent to metranidazole 200mg/10ml
32
33
34
15
(E)
90ml
760
11850
ANTHELMENTICS.
0
35
36
P-0035
Tab.Albendazole 200mg.
P-0036
Tab.Mebendazole 100mg
12020
60
2027
Tab.Mebendazole 500mg
37
38
39
P-0037
Susp. Albendazole 100mg/5ml.
P-0038
Susp. Mebendazole 100mg/5ml.
P-0039
Tab. Niclosamide 500mg
10ml
12410
30ml
2000
4
(F)
LAXATIVES/PURGATIVES/LUBRICANTS:
0
40
41
42
43
44
45
P-0040
Tab. Bisacodyl 5mg.
P-0041
Bisacodyl Suppository 0.01gm/Glycerine Suppository.
P-0042
Sodium Biphosphate 19.2gm, sodium phosphate 7.2gm,

sodium contents in 120ml 4.5gm (Enema Liquid)
P-0043
Sod. Picosulphate 7.5mg/ml Drops.
P-0044
Liq.Lactulose 3.35gm/5ml
P-0045
Syp. Magnesium Hydroxide 75% V/V + Liq. Paraffin 25%

V/\V.
100
2685
50
191
120ml
6970
15ml
18950
120ml
45948
120ml
24000
(G) DRUGS ACTING ON LIVER:
1000
46
47
48
49
50
51
P-0046
Inj. Interferone Alpha 3miu alongwith Tab. Ribavirin 400mg
P-0047
Infusion Ornithine Aspartate 5g/10ml.
P-0048
P-0049
Syp. Ornithine Aspartate 60mg, Nicotinamide 4.8mg,

Riboflavin-5mg, Phosphate Sod. 0.153mg/ml
Tab. Pancreatin 210 P.U. + Bromelain 35,000 PU,
Dimethypolysiloxan 50mg+ Sodium Dehydrocholate 20mg +
Metoclopramide 6mg.
P-0050
Tab. Silymarin 200mg
P-0051
Syp. Silymarin 105mg / 5ml.
(H)
Vial
95980
10ml
1800
120ml
15700
30
275
20
6800
120ml
4100
ANTI-EMETIC/ANTI-NAUSEANTS:
0
52
53
54
P-0052
Tab. Metoclopramide 10mg.
P-0053
Inj. Metoclopramide 10mg/2ml
P-0054
100
8296
10
7305
100
1705
300
60
25
7720
20
75
(a) Tab. Dimenhydrinate 50mg

(b) Tab.Cyclizine 50mg
55
P-0055
(a) Inj.Dimenhydrinate50mg/ml
(b) Inj.Cyclizine 50mg/ml.
56
P-0056
(a) Syp. Dimenhydrinate 12.5mg/5ml
60ml
6100
60ml
24560
10
2014
300
566
10
20
1140
50
21596
120ml
11050
(b) Syp. Cyclizine 12.5mg/5ml

57
58
59
60
61
62
P-0057
Inj. Prochlorperazine 12.5mg/ml.
P-0058
Tab. Prochlorperazine 5mg.
P-0059
Tab. Meclizine 2 HCL 25mg + Vit B6 50mg.
P-0060
Tab. Levosulpride 25mg.
P-0061
Tab.Domperidone 10mg
P-0062
Susp. Domperidone 5mg / 5ml
63
64
65
66
67
P-0063
Tab. Doxylamine Succinate 10mg + Pyridoxine HCL 10mg
P-0064
Inj.Promethazine 25mg/ml
P-0065
Inj. Ondansetron 8mg/4ml
P-0066
Tab. Ondansetron 8mg.
P-0067
30
Amp
4ml
2440
10
70
120ml
920
Syp. Promethazine HCL 25mg/5ml.

(I)
DRUGS ACTING ON CARDIOVASCULAR SYSTEM:
0
68
69
70
71
P-0068
Tab. Captopril 25mg.
P-0069
Tab. Atenolol 50mg.
P-0070
Inj. Dobutamine 250mg/ml
P-0071
20
24380
20
74300
Vial
2590
100
100
380
20
39264
20
400
25
2880
26
30
2060
30
7790
Vial
2550
Tab. Isosorbide Dinitrate 5mg.

Tab. Isosorbide Dinitrate 10mg.
72
P-0072
Tab. Isosorbide Mononitrate 20mg.

Tab. Isosorbide Mononitrate 60mg LA
73
74
75
P-0073
P-0074
P-0075
Tab. Digoxin 250mcg.

Inj. Digoxin 500mcg/2ml
Tab. Diltiazem 30mg.
Tab. Diltiazem 60mg.
76
P-0076
Inj. Dopamine 40mg/ml,(Vial of 5ml).
77
78
P-0077
P-0078
Tab. Methyldopa 250mg.
100
2401
30
2060
30
250
100
6260
100
1400
14
500
50
946
10
350
20
3150
20
44300
10
100
20
950
30
1467
30
27850
20
6350
Amp
180
30
160
110
30
2250
30
200
30
10900
30
73760
1500
20
47264
10ml
1010
Cap. / Tab.Nifedipine 10mg

Tab.Nifedipine 20mg
79
P-0079
Tab. Propranolol 10mg.

Tab. Propranolol 40mg
80
81
P-0080
P-0081
Tab. Nebivolol 5mg

Tab. Verapamil 80mg.
Tab. Verapamil 240mg SR
82
P-0082
Tab. Amlodipine Besylate 5mg.

Tab. Amlodipine Besylate 10mg.
83
84
85
P-0083
P-0084
P-0085
Inj. Propranolol 1mg/ml

Tab. Prazocin HCL 1mg.
Tab. Lisinopril 5mg.
Tab. Lisinopril 10mg.
86
87
88
89
90
P-0086
P-0087
P-0088
P-0089
P-0090
Tab. Trimetazidin Dihydrochloride 35mg.

Inj. Magnesium Sulphate 500mg/ml (10ml Amp).
Tab. Amiderone HCL 200mg.
Inj. Amiderone HCL 150mg/3ml.
Tab.Metoprolol 25mg.
91
P-0091
Tab. Aspirin 75mg (Enteric coated).

Aspirin Suppository
92
93
94
P-0092
P-0093
P-0094
Tab. Losartan Potassium 50mg.

Inj. Milrinone 1mg/ml
Inj. Metoprolol Tartrate 5mg.
5
95
P-0095
29
Inj. Isosorbide Dinitrate 10mg/10ml.
Vial
2924
96
97
P-0096
P-0097
Tab. Indapamide Hemihydrate 1.5mg SR
30
1857
10
141690
10
8250
10
3128
10
650
30
3767
10
4150
10
71600
28
1490
28
1160
2ml
180
20
19770
30
4007
30
20200
30
9074
10
5250
10
3000
20
102
10
150
30
750
20
250
10ml
500
1900
Amp
100
Tab. Atorvastatin 20mg

Tab. Atorvastatin 40mg
98
99
P-0098
P-0099
Tab. Perindopril
4mg
Tab. Carvedilol 3.125mg

Tab. Carvedilol 6.25mg
Tab. Carvedilol 25mg
100
101
P-0100
P-0101
Tab. Clopidogrel 75mg
Tab. Ramipril
Tab. Ramipril
102
103
104
P-0102
P-0103
P-0104
2.5mg
5mg
Inj. Verapamil 2.5mg/ml
Tab. Bisoprolol
5mg.
Tab. Glyceryl Trinitrate

105
P-0105
0.5mg
2.6mg
6.4mg
Tab. Clopidogeral 75mg+ Aspirin 75mg.

Tab. Clopidogeral 75mg + Aspirin 150mg
106
P-0106
Tab. Gemfibrozil 600mg.
107
P-0107
Tab. Hydrochlorthiazide 12.5mg + Irbesartan 300mg.
108
P-0108
Tab. Nifedipine (extended relesae) 30mg.

Tab. Nifedipine (extended relesae) 60mg.
109
P-0109
Inj.Glyceryl Trinitrate 1mg/1ml

Glyceryl Trinitrate 10mg Transdermal Deponit Patch
110
P-0110
Inj. Calcium Chloride 10% (100mg/ml ) Elemental Calcium

27.2mg/ml
111
P-0111
Cap.Fenofibrate 67mg
30
70
10
70
2ml
105
Amp
10
2ml
130
Amp
200
20
1480
10
2420
Amp
5110
100
100
20
455
20
155
10
10
300
10
50
30
60
30
14
20
28
480
14
50
14
370
10
50
10
Cap.Fenofibrate 200mg
112
113
P-0112
P-0113
Inj.Sod.Nitroprusside 25mg/ml
Inj.Isosorbide Mononitrate2mg/5ml
114
P-0114
Inj.Adenosine 3mg/ml
115
P-0115
Inj.Hydralazine 20mg/ml
116
117
118
119
P-0116
P-0117
P-0118
P-0119
Tab. Amlodipine 5mg + Hydrochlorthiazide 12.5mg

Tab. Rosuvastatin 10mg
Inj. Morphine 10mg /ml
Tab. Metolazone 2.5mg
Tab. Metolazone 5mg
120
P-0120
Tab. Losartan Potassium 50mg + Hydrochlorthiazide 12.5mg
121
P-0121
Tab. Lisinopril 10mg + Hydrochlorthiozide 12.5mg
122
P-0122
Tab. Nicorandil 10mg

Tab. Nicorandil 20mg
123
124
P-0123
P-0124
Tab. Ranolazine XR 500mg

Tab. Cilostazol 50mg
Tab. Cilostazol 100mg
125
126
P-0125
P-0126
Tab. Bosentan Monophydrate 62.5mg

Tab. Valsartan 80mg + Hydrochlorthiazide 12.5mg
Tab. Valsartan 160mg + Hydrochlorthiazide 25mg
127
128
P-0127
P-0128
Tab. Valsartan 5mg + Amlodipine 160mg

Tab. Ivabradine 5mg
Tab. Ivabradine 7.5mg
(J)
DRUGS USED FOR MIGRAINE:
0
129
130
P-0129
P-0130
Cap. Flunarizine 5mg

Tab. Betahistine Di-Hydrochloride
12
180
30
1005
8mg
Tab. Betahistine Di-Hydrochloride

131
132
P-0131
P-0132
16mg
30
2580
30
170
Tab. Pizotifen 0.5mg.

Tab.Zolmitriptan 2.5mg
(K)
ANTI-COAGULANTS:
0
133
134
135
136
P-0133
P-0134
P-0135
P-0136
Inj.Streptokinase 1.50miu.
138
139
140
141
P-0138
P-0139
P-0140
P-0141
Vial
8010
100
629
611
405
50
10
222
10
5ml
24
5ml
10
Tab.Warfarin Sod. 5mg

Inj. Enoxaprin (Low mol Wt. Heparin)

P-0137
180
Inj.Heparin 5000 IU.
137
Vial
40mg
60mg
80mg
Inj.Fondaparinux 2.5mg
Inj.Abciximab 2mg/ml
Inj.Tirofiban 0.25mg/ml
Inj.Eptifibatide 2mg/ml
Tab. Beraprost Sodium 20mcg
(L)
CLOTTING AGENTS:
0
142
P-0142
Tab. Eltrombopag 25mg
28
50
28
10
5290
100
2250
20
5050
Vial
Vial
Tab. Eltrombopag 50mg

143
144
P-0143
P-0144
Inj.Tranexamic Acid 250mg/5ml.

Caps Tranexamic Acid 250mg.
Caps Tranexamic Acid 500mg.
145
P-0145
Inj.Factor VIII 250Units

Inj.Factor VIII 500Units
(M) ANALGESICS/ANTIPYRETICS/ ANTIINFLAMMATORY/MUSCLE RELAXANTS/ ANTI
RHEUMATICS:
146
P-0146
Tab. Mefenamic Acid 250mg
600
4380
Tab. Mefenamic Acid 500mg

147
148
P-0147
P-0148
200
2851
200
46280
Amp
910
Vial
3850
60ml
264480
60ml
8730
20ml
3140
500
3548
30
15927
90ml
98930
20
212550
79060
40
1000
30
19700
20gm
40300
35gm
18500
30gm
Tab. Paracetamol 500mg.

Inj. Paracetamol 300mg/2ml
Inf. Paracetamol 1000mg /100ml
149
150
151
152
P-0149
P-0150
P-0151
P-0152
Susp. Paracetamol 120mg/5ml

Susp. Paracetamol BP 250mg/5ml.
Paracetamol 60mg/5ml Drops.
Tab. Ibuprofen 200mg.
Tab. Ibuprofen 400mg
153
154
155
156
P-0153
P-0154
P-0155
P-0156
Susp. Ibuprofen 100mg/5ml.

Tab. Diclofenac Sodium 50mg.
Inj. Diclofenac Sodium 75mg/3ml.
Tab. Piroxicam 10mg.

Cap/Tab. Piroxicam 20mg.
157
158
159
160
161
P-0157
P-0158
P-0159
P-0160
P-0161
Diclofenac Sod. Gel.
Oint Oleorescin of Capsicum 0.30% + Eucalyptol 0.11% +

Thymol 0.1% + Methyl Salicylate 12-17% + Menthol +
Glycerine.
Diethylamine Salicylate Gel
Inj. Nalbuphin HCL 10mg/ml.
10
2620
100
101
100
10
15
41450
10
39450
20
2200
20
Tab. Paracetamol 500mg + Codeine 15mg

Tab. Paracetamol 500mg + Codeine 30mg
162
163
164
P-0162
P-0163
P-0164
Tab. Orphenadine50mg + Paracetamol 650mg.

Tab. Tizanidine 2mg.
Cap. Celecoxib 100mg
Cap. Celecoxib
200mg.
165
166
P-0165
P-0166
Tab. Rofecoxib 12.5mg.

Tab. Meloxicam
Tab. Meloxicam
167
168
169
170
171
172
173
174
175
176
177
P-0167
P-0168
P-0169
P-0170
P-0171
P-0172
P-0173
P-0174
P-0175
P-0176
P-0177
179
P-0179
20
150
50
680
10
8260
4480
20
2050
20
8605
20
19700
100
1410
90ml
5520
100
762
20
22860
20
320
30
30
202
30
10
3700
20
4490
20
20
500
Cap. Tramadol HCL 50mg.

Inj. Tramadol HCL 100mg.
Tab. Naproxen Sodium
250mg
275mg equivalent Naproxen
Tab. Naproxen Sodium

500mg
550mg equivalent Naproxen
Tab. Nimesulide 100mg.

Tab. Ibuprofen 200mg + Pseudoephedrine 30mg.
Syp. Ibuprofen 100mg + Pseudoephedrine 30mg/5ml.
Tab. Sulphasalazine 500mg.
Tab. Diclofenac Potassium 50mg.
Cap.Thiocolchicoside 4mg
Tab. Leflunomide
10mg
20mg
100mg
Tab.Acelofenac 100mg
Tab.Diclofenac Sodium 50mg,Misoprostol 200mcg
P-0180
Inj. Papaverin HCL 15.4mg/ml
181
P-0181
Tab.Piroxicam-beta-Cyclodextrin 191.3 equal to 20mg

Piroxicam.
P-0182
Tab. Trypsin & Chymotrypsin 6:1 ratio
180
182
20
15mg
Tab. Leflunomide
P-0178
7.5mg
Tab. Leflunomide
178
10
Diclofenac Sodium Suppository 25mg

(N) ANTI-CONVULSANTS:
0
183
P-0183
Tab. Carbamazepine 200mg.
50
11530
184
P-0184
Tab. Divalprex Sodium 250mg
100
2470
100
1410
120ml
4350
30
550
30
575
10ml
150
100
335
10
2400
20
1455
120ml
800
20
4260
30
2460
50
171
30
1190
30
1530
10
14
30
Tab. Divalprex Sodium 500mg

185
186
P-0185
P-0186
Syp. Sodium Valproate equivalent to valproic Acid 250mg /

5ml
Tab. Clonazepam 0.5mg.
Tab. Clonazepam 2mg.
187
188
189
P-0187
P-0188
P-0189
Drops Clonazepam 0.25%.

Tab. Clobazam 10mg.
Tab. Topiramate
25mg
Tab. Topiramate 50mg

190
191
P-0190
P-0191
Susp. Carbamazepine 100mg/5ml

Tab. Gabapentin 300mg.
Tab. Gabapentin 100mg
192
193
P-0192
P-0193
Tab. Oxcarbazepine 300mg

Tab. Lamotrigine
25mg
Tab. Lamotrigine
194
P-0194
Tab. Zeprixodone
195
P-0195
Tab. Duloxetine 30mg.
50mg
Tab. Duloxetine 60mg.

184
P-0196
Tab. Levetiracetam 250mg
20
30
150
30
1060
100
90
100
115
5ml
200
14
1600
14
220
Tab. Levetiracetam 500mg

197
P-0197
Tab. Clomipramine 10mg

Tab. Clomipramine 25mg
198
199
P-0198
P-0199
Inj. Sodium Valproate 200mg

Cap. Pregablin 75mg
Cap. Pregablin 150mg
(0)
HYPNOTICS/SEDATIVES/ANXIOLYTICS:
0
200
P-0200
Tab. Phenobarbitone 30mg.
100
2370
201
202
203
204
205
206
207
208
209
210
P-0201
P-0202
P-0203
P-0204
P-0205
P-0206
P-0207
P-0208
P-0209
P-0210
Tab. Diazepam 5mg.
100
10135
25
649
300
20
Inj. Diazepam 10mg/2ml

Tab. Chlorpromazine 25mg
Inj. Pentazocine 30mg/ml.
2100
100
100
30
4087
30
17585
30
130
10
1580
18
310
12
4450
30
10
10
700
100
4320
Amp
270
60ml
120
Amp
3ml
1320
5ml
100
Tab. Pentazocine 25mg.

Tab. Bromazepam 3mg.
Tab. Alprazolam 0.5mg.
Tab. Buspirone HCL 5mg.
Tab. / Cap.Fluoxetine HCL 20mg.
Tab. Risperidone 1mg.
211
212
P-0211
P-0212
213
P-0213
214
P-0214
215
216
217
P-0215
P-0216
P-0217
Tab. / Cap. Atomoxetine 18mg

Cap.Temazepam 30mg
Tab. Haloperidol 5mg.
Inj. Haloperidol 5mg/ml.
Syp. Memantine 10mg/g
Inj.Flumazenil 100mcg/ml
Inj. Midazolam 1mg/1ml (3ml)
Inj. Midazolam 1mg/1ml (5ml)
(P) ANTI-DEPRESSANTS/PSYCHOSTIMULANTS.
0
218
P-0218
Tab. Mirtazapine 15mg
20
10
20
80
20
10
104
10
950

219
P-0219
Cap. / Tab. Olanzapine 5mg.

Cap. / Tab. Olanzapine 10mg.
220
221
P-0220
P-0221
Tab. Clozapine 100mg.
50
200
60
60
55
30
10
1650
14
5120
14
3240
14
520
30
250
30
1200
30
75
20
190
10
400
20
1570
10
650
30
520
30
80
650
14
14
20
1000
12
10
Cap Rivastigmine 3mg.

Cap Rivastigmine 6mg.
Rivastigmine patch 4. 6mg.
222
223
P-0222
P-0223
Tab. Fluvoxamine Maleate 50mg.

Tab. Escitalopram 10mg.
Tab. Escitalopram 20mg.
224
225
P-0224
P-0225
Cap. Venlafaxine XR 75mg.

Tab. Paroxetine HCL 12.5mg CR
Tab. Paroxetine HCL 25mg CR
226
227
228
P-0226
P-0227
P-0228
Tab. Trazodone 50mg.

Tab. Sertraline HCL 100mg.
Tab. Quetiapine 25mg CR
Tab. Quetiapine 100mg
Tab. Quetiapine 300mg SR
229
230
231
232
P-0229
P-0230
P-0231
P-0232
Tab. Memantine 10mg.

Tab. Bupropion 150mg XL
Tab. Olanzapine 6mg + Fluoxetine 6mg
Tab. Desvenlafaxine 50mg
Tab. Desvenlafaxine 100mg
233
234
P-0233
P-0234
Tab. Nortriptyline 25mg

Tab. Flunarizine 5mg
(Q)
ANTI-PARKINSONISM:
0
235
P-0235
Tab. Ropinirole 0.25mg
21
305
21
250
60
Tab. Ropinirole 1mg

236
237
P-0236
P-0237
Inj. Procyclidine HCl 10mg/2ml.

Tabs.Procyclidine 5mg.
100
1355
238
239
240
P-0238
P-0239
P-0240
Tab. Levodopa 250mg+Carbidopa 25mg.
100
290
20
650
30
30
Tab. Amantadine Sulphate 100mg

Tab. Selegiline 5mg
(R )
ANTI-HISTAMINES:
0
241
242
243
244
245
246
247
P-0241
P-0242
P-0243
P-0244
P-0245
P-0246
P-0247
Tab. Clemastine 1mg.
30
300
250
14966
50
2161
60ml
33700
60ml
34100
10
84212
50
600
50
50
30
10
450
120ml
150
10
2525
20
380
20
230
10
1030
Tab. Pheniramine Maleate 25mg

Inj. Pheniramine Maleate 22.7mg equivalent to 25mg
Pheniramine Salicylate per ml in 2ml ampoule
Syp. Pheniramine Maleate 15mg/5ml.
Syp. Cetrizine 1mg/1ml
Tab.Cetrizine 10mg
Tab. Hydroxyzine HCL
10mg
Tab. Hydroxyzine HCL 25mg

248
249
250
251
252
P-0248
P-0249
P-0250
P-0251
P-0252
Tab. Cinnarizine 25mg.

Tab. Ebastine 10mg.
Syp. Clemastine 0.25mg/5ml
Tab. Levocetrizine 5mg.
Tab. Fexofenadine 60mg
Tab. Fexofenadine 120mg
253
P-0253
Tab. Fexofenadine 60mg + Pseudoephedrine 120mg

(S)
NEUROTONICS:
0
254
255
256
257
258
P-0254
P-0255
P-0256
P-0257
P-0258
Tab. Co-Dergocrine Mesylate 1.5mg
30
3568
15ml
950
30
105
14
200
Co-Dergocine Mesylate Oral Solution
Tab. Nimodipine 30mg.
Inj. Piracetam 1gm/5ml

Tab. Galantamine (as hydrobromide) 4mg
(T)
DRUGS ACTING ON EAR:
0
259
260
261
262
263
P-0259
P-0260
P-0261
P-0262
P-0263
Gentamycine Ear Drops 0.3%.
265
266
267
268
P-0264
P-0265
P-0266
P-0267
P-0268
3600
10ml
2800
5ml
17805
10ml
1560
5ml
1300
5ml
300
5ml
200
5ml
750
5ml
1300
5ml
480
7.5ml
4700
Soda Glycerine Ear Drops.

Drops Polymyxin-B Sulphate 10,000 Units Lignocaine HCl
50mg. Propylene Glycol to make 1ml
Triamcinolone Acetonide 1mg, Neomycine 2.5mg, Gramicidin
0.25mg, Nystatin 100,000 Units Ear Drops.
Drops Ofloxacin
Drops Ofloxacin
264
7.5ml
0.3%
0.6%
Drops. Tobramycin 0.3%

Drops. Tobramycin 0.3% + Dexamethasone 0.1%
Ciprofloxacin + Dexamethasone Ear Drops.
Ciprofloxacin + Lignocaine Ear Drops.
Betamethasone 0.1% + Neomycine 0.5%Ear Drops.
(U)
DRUGS ACTING ON NASOPHARYNX:
0
269
P-0269
Xylometazoline 0.1% Nasal Drops
20ml
4560
10ml
1250
100
15ml
1450
15ml
250
15ml
60
80
50ml
60
15ml
250
Oxymetazoline 5mg / 10ml Nasal Drops

270
271
272
273
274
275
276
P-0270
P-0271
P-0272
P-0273
P-0274
P-0275
P-0276
Beclomethasone 50mcg Nasal Spray.

Flunisolide 0.025% Nasal Spray.
Azelastin HCL 0.1% Nasal Spray.
Cromoglycate Sodium 4% Nasal Spray.
Cromoglycate Sodium + Xylometazoline Nasal Spray.
Dequilinium Chloride 0.015g + Benzalkonium 0.035gm,
Alcohol 6% per 100g Oral Spray.
Normal Saline Nasal Drops
(V) THYROID AND ANTITHYROID DRUGS
0
277
278
P-0277
P-0278
Tab. Thyroxine 50mcg.
100
2433
4736
Tab. Carbimazole 5mg.
279
P-0279
Tab. Propylthiouracil 50mg
100
402
100
10
Tab. Propylthiouracil 100mg

(W) DRUGS ACTING ON ENDOCRINE/FEMALE
SYSTEM.
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
P-0280
P-0281
P-0282
P-0283
P-0284
P-0285
P-0286
P-0287
P-0288
P-0289
P-0290
P-0291
P-0292
P-0293
P-0294
P-0295
P-0296
P-0297
Inj.Medroxy Progesterone Acetate 150mg
425
50
2890
50
386
20
10
84
10
1156
4255
40
1ml
Inj. Oxytocin 5miu.

Inj.Methylergometrine 0.2mg/ml
Tab.Estrogen Conjugated 0.3mg.
Tab.Levonorgestril 1.5mg +Ethinyloestradiol 0.03mg + Tab.
Ferous Fumerate
Tab. Clomiphene Citrate 50mg.
Inj. Hydroxyprogesterone Caproate 250mg/ml.
Tab. Methyl Estrenolone 5mg+Methyl Oestradiol 0.3mg.
Inj. Dinoprost 5mg/ml
Tab. Dinoprost 3mg.
1280
30
4100
30
180
20
100
5ml
20
4626
21
915
21
300
30
170
30
50
30
150
10
1806
Vial
160
Tab. Norethistrone 5mg.

Tab. Bromocriptine Mesylate 2.5mg
Tab. Ritodrine HCL 10mg.
Inj.Ritodrine HCL 10mg/ml
Tab. Dydrogesterone 10mg
Tab.Estradiol Valerate 2mg + Norgesterol 0.5mg
Tab.Cyproterone Acetate 2mg + Ethinylestradiol 35mcg.
Cap.Danazole 200mg.
Cap.Danazole 400mg.
298
299
300
P-0298
P-0299
P-0300
Tab.Tibolone 2.5mg
Tab. Misoprostol 200mcg
Inj. Terlipressin acetate 1mg (With Diluent 5ml )
(X)
CORTICOSTEROIDS:
301
302
303
P-0301
P-0302
P-0303
Inj.Dexamethasone Sod. Phosphate 4mg/ml (1ml Vial).
25
9572
25525
1000
2594
1000
35
Inj. Hydrocortisone Sod. Succinate 250mg.

Tab. Prednisolone 5mg.
Tab. Prednisolone 5mg (Enteric Coated)
304
305
306
P-0304
P-0305
P-0306
Inj. Triamcinolone Acetonide 40mg.
3450
1ml
105
1000
154
Inj.Methylprednisolone Acetate 40mg/ml

Tab. Dexamethasone 0.5mg
(Y) ANABOLICS/DRUGS AFFECTING BONE
METABOLISM.
307
P-0307
Inj. Nandrolone Decanoate 50mg/ml.
10
20
70
30
14
2770
110
90
14
Vial
Vial
12
100
30
3ml
2gm
Inj.Nandrolone Decanoate 100mg/ml.

308
P-0308
Tab. Alendronate Sodium 10mg

Tab. Alendronate Sodium 70mg
309
P-0309
Inj. Sodium Clodronate 60mg/ml (5ml)
310
P-0310
Cap.Sodium Clodronate 400mg
311
312
P-0311
P-0312
Tab.Raloxifene HCL 60mg.

Inj. Epoetin alpha 2000 iu (PFS)
Inj. Epoetin alpha 4000 iu (PFS)
Inj. Epoetin alpha 10000 iu
313
314
P-0313
P-0314
Tab.Alendronate Sodium equivalent alendronic

acid+,Cholecalciferol 70mcg
Inj.Zoledronic acid 4mg
Inj.Zoledronic acid 5mg
315
316
317
318
319
P-0315
P-0316
P-0317
P-0318
P-0319
Tab. Azthioprine 50mg

Inj.Teriparatide 250mcg/ml
Strontium Ranelate Powder 2gm
Inj. Calcitonin 100 units / ml
Tab. Ibandronic Acid 150mg
(Z) DRUGS ACTING ON GENITO URINARY
SYSTEM/DIURETICS & BLOOD
ALKALIZERS.
0
320
321
322
P-0320
P-0321
P-0322
Tab. Norfloxacin 400mg.
10
1400
100
512
20
2144
50
140
25
15230
120ml
30020
Cap/Tab Pipemedic Acid 400mg.

Tab. Allopurinol 300mg
Tab. Allopurinol 100mg
323
324
325
P-0323
P-0324
P-0325
Tab. Potassium Chloride 500mg.

Syp. Di-Sodium Hydrogen Citrate 26.3gm / 100ml
Tab. Frusemide 20mg.
100
812
100
5317
50
1406
50
60
10
16600
30
19705
30
2480
30
180
30
220
28
204
28
310
20
140
14
30
30
30
30
20
3000ml
50
Tab. Frusemide 40mg.

326
P-0326
Inj. Frusemide 20mg

Inj. Frusemide 40mg
327
328
329
P-0327
P-0328
P-0329
Tab. Spironolectone 100mg.

Tab. Frusemide 40mg + Amiloride HCL 5mg.
Tab.Terazocin 2mg
Tab.Terazocin 5mg
330
331
332
333
334
335
P-0330
P-0331
P-0332
P-0333
P-0334
P-0335
Tab.Flavoxate HCL 200mg.

Tab.Tolterodine 2mg
Tab.Alfuzosin SR 5mg.
Tab. Doxazine Mesylate 2mg
Tab. Finasteride 5mg.
Tab. Desmopressin 0.1mg
Tab. Desmopressin 0.2mg
336
P-0336
Tab.Oxybutynin HCL 3mg

Tab.Oxybutynin HCL
337
338
P-0337
P-0338
5mg
Tab. Ethamsylate 250mg.

Glycin 1.5% solution.
339
340
341
342
343
344
345
P-0339
P-0340
P-0341
P-0342
P-0343
P-0344
P-0345
Tab. Tamsulosin 0.4mg.
20
480
30
30
250
100
52
30
300
20
20
30
120
30
9104
20
300
Tab. Potassium Citrate 10 miliequivalent

Cap. Dutasteride 0.5mg.
Sachet Sodium Bicarbonate 1.716g,Sodium
citrate0.613g,citric acid 0.702g,tartaric acid 0.858g/4gm
Tab. Dutasteride 0.5mg + Tamsulosin 0.4mg
Powder Sodium Polystyrene Sulphonate (Sachet)
Tab. Febuxostat 40mg
Tab. Febuxostat 80mg
346
347
P-0346
P-0347
Tab. Potasium Chloride 573mg + Tab. Bumetanide 0.5mg

Tab.Frusemide 40mg,Spironolactone50mg
Tab.Frusemide 20mg,Spironolactone50mg
348
P-0348
Desmopressin Nasal Spray 10mcg
2.5ml
(AA) VAGINAL PREPARATIONS/ANTI-FUNGALS.
0
349
P-0349
Vaginal Cream (a) Clotrimazole 2%
35gm
9600
5gm
600
40gm
100
40gm
1580
9180
30ml
17810
(b)Clotrimazole 10%
(c)Isoconazole 1%
(d) Fenticonazole Nitrate 2%
350
351
352
P-0350
P-0351
P-0352
Clotrimazole Vaginal pessery 500mg.

Nystatin Drops 100,000 Units/ml.
Cap. Fluconazole 50mg
10
320
13900
Cap. Fluconazole 150mg.

353
P-0353
(a) Clotrimazole lotion 1%.
60ml
700
20ml
5250
20gm
17300
(b) Clotrimazole solution 1%.

354
355
356
P-0354
P-0355
P-0356
Clotrimazole 1% Cream.
Cap.Itraconazol 100mg.
200
40gm
900
Cream Clindamycin Phosphate 2%.
357
P-0357
Cream Clotrimazole 1%+Hydrocortisone 1%
10gm
(AB)
3800
ANTIBIOTICS.
0
358
P-0358
Cap. Ampicillin 250mg.
100
10120
100
3480
10
640
10
125
Cap. Ampicillin 500mg.

359
P-0359
Inj.Ampicillin 500mg.
Inj.Ampicillin 250mg
360
361
P-0360
P-0361
Syp. Amoxycillin 125mg/5ml.
90ml
97900
100
7600
100
13240
100
5910
10
2800
Vial
50
Vial
1100
2650
12
10
4650
49750
5100
100ml
14600
100ml
600
Cap. Amoxycillin 250mg.

Cap. Amoxycillin 500mg.
362
363
364
P-0362
P-0363
P-0364
Cap. Ampicillin 250mg + Cloxacillin 250mg.

Inj. Ampicillin 250mg + Cloxacillin 250mg.
Inj. Benzyl Penicilline 0.5 MIU
Inj. Benzyl Penicilline 1 MIU
365
366
367
P-0365
P-0366
P-0367
Inj. Lincomycin 600mg(Activity )2ml.

Cap. Lincomycin 500mg.
Tab. Ofloxacin 200mg.
Tab. Ofloxacin 400mg.
368
P-0368
10
Injection/Infusion (a)Ciprofloxacin 200mg

(b) Inf. Ofloxacin 200mg
369
P-0369
Inj. Cefotaxime 500mg.
Vial
13400
Vial
54000
Vial
18800
22700
69700
Vial
5110
2640
60ml
74400
Inj. Cefotaxime 1000mg

370
371
372
373
374
375
P-0370
P-0371
P-0372
P-0373
P-0374
P-0375
Inj. Cefuroxime 750mg.

Tab. Amoxycillin 250mg+Clavulanic Acid 125mg
Tab. Amoxycillin 500mg + Clavulanic Acid 125mg.
Inj. Amoxycillin 500mg + Clavulanic Acid 100mg.
Inj. Amoxycillin 1000mg, Clavulanic Acid 200mg.
Syp. Amoxycillin 125mg, + Clavulanic Acid 31mg/5ml
35ml
13000
70ml
500
12
200
12
12
2050
12
9680
60ml
5950
60ml
9150
100
250
Vial
500
Vial
500
Vial
22800
100
8804
50ml
125000
10
24200
10
84800
60
13195
Vial
48900
Vial
173800
Vial
5000
Vial
2000
Vial
Vial
930
550
8000
10
4750
10
5520

376
P-0376
(a) Tab/Cap Cephalexin
250mg
(b) Tab/Cap Cephalexin 500mg

377
P-0377
(a) Tab/Cap Cephradine 250mg.

(b) Tab/Cap Cephradine 500mg.
378
P-0378
(a) Syp. Cephalexin 125mg/5ml.

(b) Syp.Cephradine 125mg/5ml.
379
380
P-0379
P-0380
Cap. Ampicillin 125mg + Cloxacillin 125mg.

Inj. Cephazoline 500mg.
Inj. Cephalexin 500mg.
Inj. Cephradine 500mg.
381
382
383
P-0381
P-0382
P-0383
Tab. Trimethoprim 160mg,Sulphamethoxazole 800mg.

Susp. Trimethoprim 40mg, Sulphamethoxazole 200mg/5ml.
Tab. Ciprofloxacin 250mg.
Tab. Ciprofloxacin 500mg.
384
385
P-0384
P-0385
Cap. Doxycycline 100mg.

Inj. Ceftriaxone 500mg
Inj. Ceftriaxone 1000mg
386
P-0386
Inj. Ceftizoxime 500mg

Inj. Ceftizoxime 1000mg
387
P-0387
Inj. Benzathine Penicilline 0.6 miu.

Inj. Benzathine Penicilline 1.2 miu.
388
P-0388
Inj. Gentamycin 40mg.

Inj. Gentamycin 80mg.
389
P-0389
Tab. Clarithromycin 250mg.

Tab. Clarithromycin 500mg.
390
391
P-0390
P-0391
Inj. Clarithromycin 500mg.
Vial
2160
Vial
1000
Vial
2800
60ml
1700
8950
30ml
9214
30ml
31800
13700
3800
Vial
7050
10
25900
10
29100
Inj. Ceftazidime 500mg.

Inj. Ceftazidime 1gm.
392
393
394
P-0392
P-0393
P-0394
Susp. Nalidixic Acid 250mg/5ml.

Cap. Cefixime 400mg.
Susp.Cefixime 200mg/5ml
Susp.Cefixime 100mg/5ml
395
P-0395
Inj.Cefoperazone + Salbactum
Inj.Cefoperazone + Salbactum
396
397
P-0396
P-0397
1gm
2gm
Inj. Piperacillin 4gm + Tazabactam 500mg.

Tab.Levofloxacin 250mg
Tab.Levofloxacin 500mg
398
P-0398
Inj.Levofloxacin 250mg
100ml
800
100ml
4050
Inj.Levofloxacin 500mg
399
400
P-0399
P-0400
Inj.Clindamycin 600mg/4ml
4ml
16
110
16
100
60ml
7514
700
2920
Amp
500
Amp
1000
Amp
7000
10
210
50ml
110
10ml
2000
20ml
2080
Cap.Clindamycin HCL 150mg

Cap.Clindamycin HCL 300mg
401
402
P-0401
P-0402
Syp.Clarithromycin 125mg/5ml
Cap. / Tab.Azithromycin 250mg
Cap. / Tab.Azithromycin 500mg
403
P-0403
Inj.Amikacin
100mg.
Inj.Amikacin 250mg
Inj.Amikacin 500mg
404
405
406
P-0404
P-0405
P-0406
Tab.Cefuroxime Axetil 250mg.

Susp. Cefuroxime Axetil 125mg/5ml.
Inj.Vancomycin HCL
Inj.Vancomycin HCL
500mg
1000mg
407
P-0407
Inj.Cefepime HCL
500mg
0
Inj.Cefepime HCL
408
P-0408
1000mg
Vial
Vial
Vial
3200
60ml
4400
Vial
2950
30ml
110
4910
Vial
4750
Vial
10
100
12
304
100ml
1240
Vial
1700
Vial
450
10
15
Vial
90ml
Tab. Rifaximin 200mg
Tab. Rifaximin 550mg
10
670
Cap. Fosfomycin 500mg
10
Inj.Cefpirome Sulphate 500mg

Inj.Cefpirome Sulphate 1000mg
409
410
411
412
413
414
415
416
417
418
419
P-0409
P-0410
P-0411
P-0412
P-0413
P-0414
P-0415
P-0416
P-0417
P-0418
P-0419
Inj. Cephradine 1gm.

Syp. Cephradine 250mg/5ml.
Inj. Imipenam + Cilastatin (500mg)
Clarithromycin 125mg/5ml Oral drops.
Tab. Moxifloxacin 400mg.
Inj. Moxifloxacin 400mg.
Inj. Tecopenam Sodium.
Tab. Sparfloxacin 100mg.
Tab.Linezolide 600mg
Inf. Linezolide 20mg/100ml
Inj. Meropanam 500mg
Inj. Meropanam 1g
420
421
422
423
424
P-0420
P-0421
P-0422
Tab. Sodium Fusidate 250mg

Inj. Fusidic Acid (as Diethanalamine Fusidate) 580mg
Susp. Sodium Fusidate 250mg / 5ml
P-0423
P-0424
(AC) ANTI TUBERCULOSIS
0
425
426
427
P-0425
P-0426
P-0427
Tab. Ethambutol 400mg.
100
25
100
30
30
30
Tab. Pyrazinamide 500mg.

Tab/Cap. Rifampicin 600mg.
Tab/Cap. Rifampicin 150mg
Tab/Cap. Rifampicin
300mg.
Tab/Cap. Rifampicin
428
429
430
431
432
433
434
435
P-0428
P-0429
P-0430
P-0431
P-0432
P-0433
P-0434
P-0435
40
10
30
450mg.
Syp. Rifampicin 100mg/5ml
120ml
1100
60
800
120ml
600
Vial
500
80
2260
80
1054
Vial
200
100
100
30
50
10
20
Syp. Rifampicin 100mg+Isoniazid 50mg/5ml

Syp. Isoniazid 50mg/5ml
Inj. Streptomycin 1gm.
Tab. Ethmbutol HCl 300mg,+INH 75mg +Rifampicin 150mg.
Tab. Rifampicin 150mg+Isoniazid 75mg+Pyrazinamide 400mg
+ Ethambutol 275mg.
Inj.Kanamycin Suphate 1gm.
Tab.Thiacetazone 50mg + INH 100mg
Tab.Thiacetazone 150mg + INH 300mg
436
437
P-0436
P-0437
Tab.Ethionamide 250mg
Tab. Cycloserin 250mg.
(AD )
ANTIMALARIALS.
0
438
439
440
441
442
443
444
445
446
P-0438
P-0439
P-0440
P-0441
P-0442
P-0443
P-0444
P-0445
P-0446
Inj. Chloroquine Phosphate eq to 200mg/5ml
100
15ml
3250
500
392
10
2550
10
Susp. Sulphadoxin 500mg+Pyrimethamine 25mg/5ml.

Tab. Chloroquine Sulphate/Phosphate 250mg.
Tab. Sulfadoxine 500mg+Pyrimethamine 25mg.
Tab.Halofantrine HCL 250mg.
Cap. Artemether 40mg.
Syp. Artemether 15mg/5ml
80ml
100
1000
1126
16
640
60ml
600
Inj. Artemether 80mg/ml.

Tab. Artimether 80mg + Lumefantrine 480mg.
Tab. Artimether 20mg + Lumefantrine 120mg.
447
P-0447
Syp. Arthmether 15mg/5ml + Lumefantrine 9omg/5ml.

(AE) ANTI-DIABETICS.
100
448
449
450
451
P-0448
P-0449
P-0450
P-0451
Tab. Glibenclamide 5mg.
60
31681
10ml
4862
10ml
40530
50
63200
30
5000
20
6250
20
5714
10ml
6900
30
1300
30
65
20
24994
14
250
14
1200
14
100
14
2400
14
3000
Vial
375
14
509
20
300
20
300
30
30
100
30
1210
Inj. Insulin NPH (Isophane Insuline) 100 Units/ml.

Inj. Humen Insulin 70/30 (Recombinent DNA origin).
Tab. Metformin 500mg.
Tab. Metformin 850mg
452
P-0452
Tab. Gliclazide 30mg. MR

Tab. Gliclazide 60mg. MR
453
454
P-0453
P-0454
Inj. Insulin Plain 100 Units/ml (Regular)
Tab. Acarbose 50mg.
Tab. Acarbose 100mg.

455
456
P-0455
P-0456
Tab.Glimepiride 2mg
Tab. Pioglitazone
15mg
Tab. Pioglitazone 30mg

Tab. Pioglitazone
457
P-0457
45mg
Tab. Pioglitazone 15mg + Metformin 500mg.
Tab. Pioglitazone 15mg + Metformin 850mg.

458
459
460
P-0458
P-0459
P-0460
Salt Free Albumin 20%(100ml)

Tab. Sitagliptin 50mg
Tab. Gliclazide 80mg + Metformin 500mg
Tab. Gliclazide 160mg + Metformin 1000mg
461
P-0461
Tab. Repaglinide 1mg
Tab. Repaglinide 2mg

462
P-0462
Tab. Glibenclamide 5mg + Metformin 500mg
(AF) VITAMINS/MINERALS/HAEMATINICS:
0
463
P-0463
Syp. Calcium.
120ml
464
P-0464
21300
(a) Tab. Calcium Gluconate.
200
110
50
30
100
100
24600
(b) Tab. Calcium Lactate.

Tab. Calcium Phosphate
(d) Tab. Calcium Carbonate.
(e) Tab. Calcium Acetate
465
466
P-0465
P-0466
25
8710
120ml
27650
120ml
500
56
4530
30
35600
100
10700
30
9550
120ml
47200
20
7010
10ml
1450
40
1950
10
350
50
1874
30
7817
Inj. Thiamine 100mg, Pyridoxine 100mg, Cyanocobalamine

1000mcg/3ml.
Syp. Ferrous Sulphate

Syp. Ferrous Gluconate.
467
P-0467
(a)Tab. Ferrous Sulphate with Folic Acid.

(b)Tab. Ferrous Fumerate with Folic Acid.
468
P-0468
Tab. Folic Acid 5mg.
469
P-0469
Tab. Vit-B-Complex Sugar coated.
470
P-0470
Syp. Vit. B.Complex each 15ml contains:Vitamin B1 3mg,Vitamin B2 3mg,Pyridoxine

2mg,Nicotinamide 23mg
471
472
473
P-0471
P-0472
P-0473
Tab. Pyridoxine 50mg.

Drops Multivitamin each 0.6ml contains:Vitamin A 1.5mg, Vitamin D 10mcg Vitamin B1 1.5mg,Vitamin
B2 1.2mg + Vitamin B6 0.5mg
Tab. Vitamin C 500mg.
474
P-0474
Inj. Calcitriol (Vitamin D analogue) 1mcg/ml.
475
P-0475
Inj. Calcium Gluconate 10ml.
476
P-0476
Tab. Multivitamin with Minerals.
477
478
479
P-0477
P-0478
P-0479
Tab. Alfacalcidol 0.50mcg.
Inj. Cholecalciferol (Vit-D3) 250,000 IU equal to 5mg/ml

(Amp).
481
P-0481
Inj. Phytomenadione 10mg (2mg/0.2ml).
482
P-0482
Cap. Ferrous Sulphate 150mg (eq to 47mg Fe) + Folic Acid

0.5mg + Thiamine mononitrate 2mg + Riboflavine 2mg +
Pyridoxine HCL 1mg+ Nicotinamide 10mg + Ascorbic Acid
50mg.
483
P-0483
Tab. Calcium + Vit-D
485
486
487
P-0485
P-0486
P-0487
20ml
210
10
640
10600
500
56
15230
30
40294
3040
10
600
20
24060
10
5010
Inj. Iron Sorbitol Citric Acid Complex BP equivalent to

75mg Iron+Hydroxocobalamine Acetate 75mcg as vit-B12 +
Folic Acid 750mg.
P-0480
P-0484
8280
Drops Alfacalcidol 0.2mcg/ml
480
484
20
Inj.Iron Sucrose 20mg/ml

Tab. Iron Polymaltose Complex equal to Iron 100mg, Folic
Acid 0.35mg.
Tab .Mecobalamine 500mcg
Inj. Mecobalamine 500mcg/ml
(AG) EXPECTORANTS/COUGH SUPPRESSANTS/
100
ANTI- TUSSIVE/BRONCHOSPASM RELAXANTS.
0
488
489
490
P-0488
P-0489
P-0490
Syp.Dextromethorphen 10mg, Pseudoephedrine 20mg +

Chlorpheniramine Meleate 2mg
60ml
49400
Syp. Triprolidine HCI 1.25mg, Pseudoephedrine HCI

30mg/5ml.
90ml
2050
120ml
254800
120ml
8600
120ml
178600
120ml
1100
100
4660
(a)Syp.Aminophylline 32mg, Diphenhydramine

8mg,Ammonium Chloride 30mg, Menthol 0.98mg, Alcohol 5%
per 5ml.(NORMAL)
(b)Syp.Aminophylline 32mg, Diphenhydramine
8mg,Ammonium Chloride 30mg, Menthol 0.98mg, Alcohol 5%
per 5ml.(SUGAR FREE)
491
492
493
P-0491
P-0492
P-0493
Syp Ammonium Chloride 100mg,Sodium Citrate 60mg,

Chlorpheniramine Maleate 2mg, Ephedrine HCI 7mg,
Menthol 1mg/5ml.
Syp Theophylline Sodium Glycinate 150mg / 5ml
Tab.Theophylline 300mg.
494
P-0494
Inj. Aminophylline 250mg/10ml.
495
P-0495
Inj. Salbutamol 0.5mg/ml.
496
P-0496
Tab. Salbutamol 2mg.
118
60
100
497
498
499
500
501
502
503
504
P-0497
P-0498
P-0499
P-0500
P-0501
P-0502
P-0503
P-0504
11760
Syp. Pholcodine 5mg / 5ml
120ml
700
9850
9580
60ml
25000
100
2070
1020
2450
200 Doses
150
200 Doses
50
840
10
1520
10
1250
14
200
14
1800
14
21800
2650
50
Salbutamol 100mcg per Inhalation, 200 Puff

Salbutamol 100mcg, Beclomethasone Dipropionate 50mcg,
200 Inhalation.
Syp. Terbutaline 1.5mg/5ml.
Tab. Terbutaline Sulphate 2.5mg.
Budesonide 200mcg + Formeterol 6 mcg Inhaler

Solution Ipratropium Bromide 250mcg/ml for nebuliser.
Spray Ipratropium Bromide 40mcg/Dose.
Spray Ipratropium Bromide 20mcg/Dose.
505
P-0505
Inhaler Salmetrol + Fluticasone 25mcg/250mcg.

(CFC Free)
506
P-0506
Tab.Bambuterol HCL 10mg.

Tab.Bambuterol HCL 20mg.
507
P-0507
Tab. Montelukast 4mg

Tab. Montelukast
Tab. Montelukast
508
P-0508
5mg
10mg.
Inhaler Beclomethasone Dipropionate 50 mcg

509
510
511
512
P-0509
P-0510
P-0511
P-0512
Syp. Acefylline 125mg/5ml.
120ml
5850
30
300
20ml
3250
270
Sachets Acetylcysteine 200mg / 3gm

Salbutamol Solution 5mg/ml.
Formeterol Fumerate 6mcg + Beclomethasone Diapropionate
100mcg / Dose
513
514
P-0513
P-0514
Monteleukast 4mg Powder
14
450
Vial
2000
Beclomethasone Diproprionate Solution for Nebulisation

(AH) OPHTHALMIC PREPARATIONS:
0
515
516
517
518
519
520
521
522
523
524
525
P-0515
P-0516
P-0517
P-0518
P-0519
P-0520
P-0521
P-0522
P-0523
P-0524
P-0525
Nepafenac 0.1% Eye Drops
5ml
3660
10ml
47200
5gm
1840
10ml
5830
3.5gm
250
3.5gm
3230
5ml
6060
15ml
110
7.5ml
3900
30
940
5ml
700
5ml
1830
5ml
215
15ml
240
10ml
3670
5ml
255
15ml
306
5ml
1260
5ml
100
5ml
4820
5ml
4700
5ml
7040
Chloramphenicol Drops 0.5%.
Oint. Chloramphenicol 1%.

Sulphacetamide drops 20%.
Oint. Chloramphenicol 1%, Hydrocortisone Acetate 0.5%.
Polymyxin-B Sulphate 10,000 units Neomycin Sulphate
3,400 units Oint.
Prednisolone Acetate 1% Drops.
Homatropine Drops 2%.
Betamethasone 0.1% drops.
Tab.Acetazolamide 250mg.
(a) Drops Betoxalol 0.5%
(b)Timolol 0.5%
Levobunolol 0.5%.
526
527
528
529
530
531
532
533
534
P-0526
P-0527
P-0528
P-0529
P-0530
P-0531
P-0532
P-0533
P-0534
Drops Pilocarpine 2%.

Sodium Cromoglycate drops 4%.
Phenylephrine 10% Drops.
Tropicamide1% Drops.
Drops Dexemethasone 01% Neomycine Sulphate 0.35%,
Hyperomellose 0.5%, Polymyxin B-Sulphate 6000 units/ml.
Drops Pyrilamine maleate 0.1%, Phenylepherine HCL 0.12%.
Diclofenac Sod. Eye Drops.
Ciprofloxacin Eye Drops.
Tobramycine Eye Drops.
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
P-0535
P-0536
P-0537
P-0538
P-0539
P-0540
P-0541
P-0542
P-0543
P-0544
P-0545
P-0546
P-0547
P-0548
P-0549
P-0550
P-0551
P-0552
P-0553
P-0554
P-0555
P-0556
P-0557
P-0558
P-0559
Acyclovir Ointment.
Drops .Proparacaine HCL 0.5% + Benzalkonium Chloride
0.01%
4.5gm
740
15ml
196
15ml
232
15ml
1846
5ml
5160
15ml
105
2.5ml
580
6gm
14924
5ml
150
5ml
1550
2.5ml
680
5ml
270
5ml
440
5ml
710
5ml
560
5ml
4100
5ml
410
5ml
2400
15ml
820
5ml
2150
5ml
1830
10ml
5560
3gm
420
10gm
500
5ml
5350
Drops. Cyclopentolate HCL 1%.

Drops Naphazoline HCL 0.025% + Phenarmine Maleate 0.3%.
Drops Fluoromethalone 0.1% + Tetrahyrozoline HCL 0.25%
Drops Atropine Sulphate 1%.
Drops Travoprost 40mcg/ml.
Oint. Polymixin B Sulphate 10000 u + Zinc Bacitracin 500
Units/gm.
Drops Dorzolamide HCL 2%.
Drops Dorzolamide HCL 2% + Timolol Maleate 0.5%.
Drops Latanoprost 50mcg/ml
Drops Brinzolamide 1%
Drops Brimonidine Tartrate 0.2%
Drops Ofloxacin 0.3%.
Drops Fusidic Acid 1%
Drops Tobramycin 0.3% + Dexamethasone 0.1%
Drops Natamycin 5%
Drops Dexamethasone 0.1%.
Drops Sod. Cromoglycate 40mg + Tetrahydrozoline HCL
0.5mg/ml.
Drops Lodoxamide Tromethamine 0.1%.
Drops Chloramphenicol 0 .5% + Dexamethasone 0.1%.
Drops Polyvinyl Alcohol 1.4%.
Oint. Miconazol Nitrate 2%
Polyacrylic Acid gel
Drops Moxifloxacin 0.5%
(AI) DERMATOLOGICAL PREPARATIONS.
250
560
561
562
563
564
565
566
567
P-0560
P-0561
P-0562
P-0563
P-0564
P-0565
P-0566
P-0568
Oint (Skin) Polymyxin B.Sulphate 10,000 Units, Zinc

Bacitracin 500 units.
20gm
71630
10gm
59800
30gm
20100
10gm
42100
10gm
20100
20gm
100
60ml
140
20
100
10
1565
10gm
3840
10gm
2510
10gm
4540
15gm
9560
5gm
8020
40gm
500
20gm
1910
30
385
10
4330
10gm
1050
15gm
610
60ml
300
20
210
20
100
10gm
350
10gm
1150
10gm
110
Betamethasone Skin Oint. 0.1%.

Permethrine 5% Cream.
Cream Betamethasone 0.1%.
Cream Clobetasol Propionate 0.05%.
Ext. Cepae 10gm + Hepasim Sod.5000 IU + Allantoin 1gm +
water Soluble fat free hydrogel base gel.
Susp. Acyclovir 200mg/5ml.
Tab. Acyclovir 400mg
Tab. Acyclovir 800mg
568
P-0568
Cream Hydroquinone 2%.

Cream Hydroquinone 4%.
569
570
571
572
573
574
575
576
577
P-0569
P-0570
P-0571
P-0572
P-0573
P-0574
P-0575
P-0576
P-0577
Cream Tretinoin 0.05%.

Oint.Betamethasone Dipropionate 0.05% + Salicylic Acid 3%
Cream Hydrocortisone 1%.
Cream Benzoyl Peroxide 4%.
Oint. Bacitracin Zinc B.P 500u + Polymixin B Sulphate
10,000u, Lignocain B.P 40mg/gm.
Cap. Isotretinoin 20mg.
Tab. Terbinafine 250mg.
Clindamycine Gel.
Mupirocine Ointment 2%
578
P-0578
Betamethasone Lotion.
579
P-0579
Tab.Ivermectin 3mg
Tab.Ivermectin 6mg
580
581
582
P-0580
P-0581
P-0582
Cream Acyclovir 5%
Isotretinion Gel 0.05%
Isotretinion + Clindamycine Gel
583
584
P-0583
P-0584
Benzyl Peroxide 5% + Clindamycin 1% Gel / Cream
10gm
180
15gm
6920
15gm
150
10gm
600
10gm
750
Cream Fucidic acid 2%

Fucidic Acid 2% Ointment
585
P-0585
Fluticasone Cream 0.05%

Fluticasone Ointment 0.05%
(AJ)
LOCAL/ GENERAL ANAESTHETICS:
0
586
587
P-0586
P-0587
Inj.Glycopyrrolate 0.5mg + Neostigmine methylsulphate

2.5mg/1ml Amp
10
322
10ml
390
2ml
730
10ml
870
4ml
300
2ml
5180
15gm
17196
20gm
900
50
72
50
764
50
31
50ml
30
100ml
319
250ml
65
20ml
4060
1ml
350
1ml
3820
1ml
320
5ml
400
10ml
100
Inj.Ketamine HCL 50mg/ml.

Inj.Ketamine HCL 50mg/ml.
588
P-0588
Inj. Bupivacaine 0.5%.(Plain) (10ml )

Inj.Bupivacaine Spinal 0.5% (4ml)
Inj.Bupivacaine Spinal 0.75% (2ml)
589
P-0589
Lignocaine Gel. 2%.

Lignocaine Gel.5%
590
P-0590
Inj. Lignocaine 2% (2ml)

Inj. Lignocaine 2%
591
592
593
594
595
596
597
598
599
(10ml)
P-0591
Inj. Lignocaine 2% with Adrenaline 0.001%.
P-0592
Lignocaine Solution 4%.
P-0593
P-0594
P-0595
P-0596
P-0597
P-0598
P-0599
Inhaler Isoflorane.
Inhaler Sevoflorane
Inj .Propofol 10mg/ml
Inj.Ephedrine HCL 30mg/ml
Inj. Adrenaline 1mg/ml
Inj.Ketorolac 30mg/ml
Inj.Fentanyl 0.5mg/ml
Inj.Fentanyl 0.5mg/ml
600
601
602
P-0600
P-0601
Inj. Etomidate 20mg/10ml
10ml
100
2ml
2460
1ml
1140
Inj. Nor-Adrenaline 1mg/ml
P-0602
Inj. Phenyl Epherine 10mg/ml

(AK) ANAESTHETICS ADJUVANTS
(NEUROMUSCULAR BLOCKER).
603
P-0603
Inj. Atracurium Besylate 10mg/ml (2.5ml)
560
1310
370
2ml
506
2ml
2430
30
100
Inj. Atracurium Besylate 10mg/ml (3ml)
Inj. Atracurium Besylate 10mg/ml

604
605
606
P-0604
P-0605
P-0606
(5ml)
Inj. Pancuronium Bromide 4mg/2ml

Inj. Suxamethonium Chloride 100mg.
Tab. Baclofen 10mg
(AL) ANTISEPTIC/DISINFECTANTS
0
607
608
P-0607
P-0608
Chloroxylenol Solution B.P.
4.5 Litre
100
500ml
25
500ml
1000ml
450ml
8934
60ml
2340
450ml
1890
60ml
50ml
250
200ml
200
450ml
Chlorhexidine Gluconate 1.5% Solution.

Chlorhexidine Gluconate 4% GEL
609
610
P-0609
P-0610
Chlorhexidine Gluconate Solution 1.5% + Cetrimide 15%.

Skin Lotion Povidone Iodine 10gm/100ml.
Skin Lotion Povidone Iodine 10gm/100ml.
611
P-0611
Surgical Scrub Povidone Iodine 7.5mg/100ml

Surgical Scrub Povidone Iodine 7.5mg/100ml
612
613
614
P-0612
P-0613
P-0614
Tetrachlorodecaoxide Solution.
Chlorhexidine Gluconate w/v 0.2% Mouth Wash.
Alcohal base Antiseptic Lotion/gel.
(AM)
DRESSINGS.
0
615
616
P-0615
P-0616
Cotton Bandages Guaze BPC specification Loose Woven

width 1 mlength 30.m.
30mtr
4058
12
4244
Cotton Bandages BPC 5cm x 6m.
617
618
619
620
621
622
623
624
P-0617
P-0618
P-0619
P-0620
P-0621
P-0622
P-0623
P-0624
Cotton Bandages BPC 6.5cm x 6m.
12
3100
7800
7650
500gm
13310
7840
5600
5600
10
550
100
Cotton Crape Bandages 7.5cm x 4.5m.

Cotton Crape Bandages 10cmx 4.5m.
Cotton Wool BPC 500gm.
Plaster of paris Bandages BPC Cal. Sulphate Hydrated 90%
Kubab Gauze Cloth 10% 10cmx 2.7m.
Adhesive Plaster of paris, spool of 7.5cmx10m.
Bandages Plaster of paris 15cmx2.7meter.
(a) Lano Paraffin Gauze Sterilized dressing impregnated
with Framycetin 10cmx 10cm:
(b)Antibiotic Tulle Dressing
(c)Fucidin Intertulle.
(d)Chlorinated Lime and boric acid dressing
(e) Anticeptic Tulle Dressing
625
P-0625
Cream silver Sulphadiazine 1%
50gm
3640
250gm
150
Cream silver Sulphadiazine 1%

626
P-0626
Calcium Sodium Alignate Dressing
1
(AN)
627
628
P-0627
P-0628
I.V. SOLUTIONS:
Inf. Sodium Chloride 4g/litre, Sod, Lactate 5.9gm/litre,

potassium chloride 2.6gm per litre with infusion set.
0
0
500ml
50
500ml
50
500ml
Inj. Dextran 6% with Infusion set.

Inj. Dextran 4% with Infusion set.
629
P-0629
Inj. Dextrose 25% Amp with Infusion Set
4650
Inj. Dextrose 25% Amp with Infusion Set
100
630
631
632
633
634
P-0630
P-0631
P-0632
P-0633
P-0634
Inj. Dextrose in water 10% with Infusion set.
1000ml
7400
5ml
30600
Inj. Distilled water 5ml.
Inj. Dextrose 25% with Infusion Set.
1000ml
620
1000ml
30500
1000ml
5650
Inj. Dextrose 5% with Infusion set.

Inj. Dextrose 5% with Normal Saline with Infusion set
635
636
P-0635
P-0636
Inj. Hartmans Solution with Infusion Set.
1000ml
92600
500ml
3000
500ml
820
10ml
5310
1000ml
49220
500ml
3540
500ml
935
Inj. Polygelline 35gm with Electrolyte per 1000ml with

Infusion set.
500ml
2420
Infusion contains Dextrose 5%+Sodium Chloride 0.45% (1/2

Normal Saline)
500ml
100
Infusion contains Dextrose 5%+Sodium Chloride 0.45% (1/2

Normal Saline)
1000ml
500ml
7140
500ml
1725
500ml
20
250ml
500ml
500ml
10
1000ml
500
2000ml
500ml
500ml
Inj. Mannitol with Infusion set 10%.

Inj. Mannitol with Infusion set 20%.
637
638
639
640
641
642
643
644
P-0637
P-0638
P-0639
P-0640
P-0641
P-0642
P-0643
P-0644
Inj. Potassium Chloride 15%.

Inj. Normal Saline 0.9% with Infusion set.
Inj. Normal Saline 0.45% with Infusion set
Inj. Sodium Bicarbonate 8.4%.
Infusion contains Dextrose 4.3% + Sodium Chloride 0.18%.

Amino acid Solution I/V with drip set.
Amino acid with electrolytes + Carbohydrate + Vitamins
alongwith drip set.
645
P-0645
Lipid Solution I/V with drip set.

Lipid Solution I/V with drip set.
646
647
P-0646
P-0647
Infusion Containing Ca. Chloride 2H2O, Potassium Chloride

1.5gm, Sodium Acetate 3H2O 2.16gm, Dextrose Anhydrous
50gm, water for Inj.)
Peritonial Dialysis Solution.
Peritonial Dialysis Solution.
648
649
P-0648
P-0649
Inf. Hydroxyethyl Starch (HES2000/0.5) 6% + Sodium

Chloride 9gm/litre
Inf. Succinylated Gelatin 20gm
(AO)
ONCOLOGY:
0
650
P-0650
Inj. Cyclophosphamide 200mg
Vial
Vial
Vial
50
Vial
20
Vial

651
652
P-0651
P-0652
Inj. Vincristine 1mg.

Inj.Doxorubicin (Adriamycin)
10mg
653
654
655
P-0653
P-0654
P-0655
20mg
Vial
10
Vial
50
Vial
20
30
740
10ml
50
20ml
500
Vial
30
Vial
105
Vial
110
100
254
10
Vial
Vial
30
Vial
Vial
0
20
Vial
Vial
Vial
Vial
20
Vial
20
100
15
100
30
50
Vial
Vial
100
50
285
50mg
Inj. Daunomycin 20mg.

Tab. Tamoxifen 10mg.
Inj. Fluorouracil 250mg
Inj. Fluorouracil 500mg
656
657
P-0656
P-0657
Inj. Vinblastine Sulphate 10mg.

Inj. Methotrexate 15mg
Inj. Methotrexate 50mg
658
P-0658
Tab. Methotrexate 2.5mg

Tab. Methotrexate 10mg.
659
P-0659
Inj. Cisplatinum 10mg

660
P-0660
Inj. Bleomycine HCL 15gm.
661
P-0661
Inj. Dactinomycin 0.5mg.
662
P-0662
Inj. Cytarabine
100mg,
Inj. Cytarabine 500mg.

663
664
665
666
667
668
669
670
671
P-0663
P-0664
P-0665
P-0666
P-0667
P-0668
P-0669
P-0670
P-0671
Inj. Dacarbazine 200mg.

Inj. Etoposide 100mg.
Cap. Hydroxyurea 500mg.
Tab. Megestrol Acetate 40mg.
Tab. Mercaptopurine 50mg.
Cap. Procarbazine 50mg.
Inj. Vinorelbine 50mg.
Inj. Paclitaxil 30mg.
Tab. Cyclosporin-A
25mg
Tab. Cyclosporin-A
Tab. Cyclosporin-A
672
673
P-0672
P-0673
50mg
50
50
50
50
30
Vial
10
Vial
10
Vial
Vial
10
Vial
60
Vial
20
Vial
50
Vial
Vial
100
100
Vial
Vial
Vial
20
50
28
20
30
Vial
210
2250
120
100mg.
Tab Cyproterone Acetate 50mg

Inj. Epirubicin HCL 10mg.
Inj. Epirubicin HCL 50mg.
674
P-0674
Inj. Carboplatin
50mg
Inj. Carboplatin 200mg.

675
676
P-0675
P-0676
Inj. Mesna 400mg, 100mg/ml (4ml Amp).

Inj. Ifosfamide 500mg.
Inj. Ifosfamide 1000mg
677
P-0677
Inj. Gemcitabine 200mg.

Inj. Gemcitabine 1gm.
678
679
680
681
682
683
684
685
P-0678
P-0679
P-0680
P-0681
P-0682
P-0683
P-0684
P-0685
Tab. Flutamide 250mg.

Inj. Goserelin Acetate 3.6mg.
Inj.Topotecan 4mg
Inj. Docetaxel 20mg (With Solvent).
Inj. Ca.Leucovorin /Ca. Folinate/ Folinic Acid (As Calcium
Salt)50mg.
Tab.Cyclophosphamide 50mg
Tab. Anastrazol 1mg
(a) Inj. Pamidronate Disodium
15mg
(b) Inj. Pamidronate Disodium 30mg

686
687
688
P-0686
P-0687
P-0688
Cap. Pamidronate Disodium 100mg

Inj. Filgrastim 300mcg/ml
Inj.Octreotide Acetate
0.05mg
Inj.Octreotide Acetate 0.1mg

Inj.Octreotide Acetate 20mg
689
P-0689
Tab. Capecitabine 500mg
690
P-0690
Tab. Mycophenolate Mofetil 500mg.
50
510
120
Vial
30
31
20ml
25
10
10
10
100
60
30
30
28

691
692
693
694
695
P-0691
P-0692
P-0693
P-0694
P-0695
Inj.Leuprorelin Acetate 3.75mg

Tab.Letrozole 2.5mg
Inj. Trastuzumab 440mg
Tab. Chlorambucil 2mg
Cap. Thalidomide 50mg
Cap. Thalidomide 100mg
696
P-0696
Tab. Imitinab 100mg

Tab. Imitinab 400mg
697
698
P-0697
P-0698
Tab. Everolimus 5mg

Tab. Nilotinib 200mg
(AP) IMMUNOGLOBULIN:
0
699
700
P-0699
P-0700
Inj. Rho. (D) Immune Globulin (Human) 300mcg
Amp
685
Vial
85
Inj. Hepatitis-B Immune Globulin 200iu/ml

(AQ) ANTIVIRALS.
0
701
702
703
704
705
P-0701
P-0702
P-0703
P-0704
P-0705
Tab. Telbivudine 600mg
28
20
10ml
600
Inj. Acyclovir 500mg.

Tab. Adefovir Dipivoxil 10mg.
30
30
770
30
Tab. Entecavir 0.5mg

Tab. Tenofovir Disoproxil 300mg
(AR) ANTIDOTES.
0
706
707
708
P-0706
P-0707
P-0708
Inj. Desferrioxamine Mesylate 500mg.
10
4550
10
50
30
220
30
90
Tab.Penicillamine 250mg
Tab.Deferasirox 400mg
Tab.Deferasirox 100mg
709
P-0709
Inj. Protamine Sulphate 10mg/ml
5ml
(AS) ANDROGENS
0
710
P-0710
Inj.Testosterone Oenanthate 250mg
1ml
100
0
20
4500
(AT) VASOTHERAPEUTICS
711
P-0711
Tab. Diosmin 450mg + Hesperidine 50mg
P-0712
Inj. Sodium Tetradecyl Sulphate 20%
Amp
Amp
55
0
30
360
0
Disposable Syringes 1CC
49500
Disposable Syringes 1CC Insuline
206050
Disposable Syringes 2.5CC
211000
911000
173300
1
40
40
13700
490
1615
712
P-0713
Inj. 5% Phenol with almond oil
713
(AU)AMINOQUINOLONES
P-0714
714
Tab.Hydroxychloroquinine sulphate 200mg

(AV)DISPOSABLE SYRINGES
P-0715
715
716
P-0716
P-0717
717
P-0718
718
P-0719
719
P-0720
720
P-0721
721
722
723
P-0722
P-0723

Note:
1. For biological products, the firm will produce batch wise cold chain data from the source of
origin & thermo log data from factory to ware house.
2. Syrups Bottles shall be supplied alongwith spoon and leaflets where applicable.
3. Injectables and Tablets packed in cartons shall be supplied with leaflets
BIDDING DOCUMENT FOR

PURCHASE OF MEDICINES,
INJECTION INTERFERON AND
DISPOSABLE SYRINGES
YEAR 2015-2016
PUNJAB EMPLOYEES SOCIAL SECURITY INSTITUTION

(HEAD OFFICE)
3/A, GULBERG-V, LAHORE.
Ph. No.042-99263122
INSTRUCTIONS TO BIDDERS
1.
Source of Funds:
THE PUNJAB EMPLOYEES SOCIAL SECURITY INSTITUTION
(PESSI), has allocated the budget for purchase of medicines for PESSI Hospitals/Directorates under the
relevant head of Account.
2.
Eligible bidders:
This Invitation for Bids is open to all Manufacturers and in case of
imported goods, their Sole Agents / Importer in Pakistan, Pre-qualified with the PESSI for supply of
Drugs / Medicines, on Free Delivery to CMSD, Defence Road, Lahore. The importer /sole agent must
possess a valid authorization from the Foreign Principal / Manufacturer and drugs sale license issued by
the competent authority in Pakistan and in case of manufacturer they should have a documentary proof
of valid drugs manufacturing license. The bidder shall also have to submit a copy of registration
certificate from Ministry of Health, Islamabad / Drug Regulatory Authority Pakistan and letter for Pre
qualification from PESSI. The bidders shall not be under a declaration of ineligibility for corrupt and
fraudulent practices, declared by any Government (Federal/Provincial/District), a Local Body or a
Public Sector Organization.
3.
Eligible Goods and Services: All goods and related services to be supplied under the contract
shall have their origin in eligible source countries and all expenditures made under the contract shall be
limited to such goods and services. For these purposes, the term Goods includes any Goods that are
the subject of this Invitation for Bids and the term Services shall includes related services such as
transportation, insurance etc. The origin means the place where the goods are mined, grown, or
produced, or the place from which the related services are supplied. Goods are produced through
manufacturing or processing, or substantial and major assembly of ingredients / components, a
commercially recognized product results that is substantially different in basic characteristics or in
purpose or utility from its components.
4.
Cost of Bidding: The bidder shall bear all costs associated with the preparation and submission
of its bid, and the Procuring Agency shall in no case be responsible or liable for those costs, regardless
of the manner or outcome of the bidding process.
THE BIDDING PROCEDURE
Single Stage Two Envelopes Bidding Procedure shall be applied:
5.
i.
The bid shall comprise a single package containing two separate envelopes. Each envelope
shall contain separately the Financial Proposal and the Technical Proposal;
ii.
The envelopes shall be marked as FINANCIAL PROPOSAL and TECHNICAL

PROPOSAL in bold and legible letters to avoid confusion;
iii.
Initially, only the envelope marked TECHNICAL PROPOSAL shall be opened;
iv.
The envelope marked as FINANCIAL PROPOSAL shall be retained in the custody of

Procuring Agency without being opened;
v.
The Procuring Agency shall evaluate the Technical Proposal, without reference to the price
and reject any proposal which do not conform to the specified requirements;
vi.
During the technical evaluation, no amendments in the technical proposal shall be

permitted;
vii.
The Financial Proposals of bids shall be opened publicly at a time, date and venue to be
announced and communicated to the bidders in advance;
viii.
After the evaluation and approval of the technical proposal, the Procuring Agency shall at a
time within the bid validity period, publicly open the financial proposals of the technically
accepted bids only.
ix.
The financial proposal of bids found technically non-responsive shall be returned unopened to the respective bidders.
x.
The bid found to be the lowest evaluated bid shall be accepted.

THE BIDDING DOCUMENTS
6.
Content of Bidding Documents

i.
The goods required, bidding procedures, and Contract terms are prescribed in the
bidding documents. In addition to the Invitation for Bids, the bidding documents shall include:a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.
ii.
Invitation to Bids.
Instructions to bidders;
General Conditions of Contract;
Special Conditions of Contract;
Schedule of Requirements.
Delivery time, completion schedule and price schedule.
Contract Form;
Manufacturers Authorization Form;
Bid Form;
Bid Evaluation Criteria
Technical specification comprising list of medicines and Drug Specification
Proforma.
The bidder is expected to examine all instructions, forms, terms, and specifications in
the bidding documents.

iii
Failure to furnish all information required by the bidding documents or to submit a bid
not substantially responsive to the bidding documents in every respect shall be at the bidders risk and
may result in the rejection of its bid.
7.
Clarification of Bidding Documents: A prospective bidder requiring any clarification of the
bidding documents may notify the Procuring Agency, in writing at the Procuring Agencys address,
indicated in the Invitation for Bids. The Procuring Agency shall respond in writing to any request for
clarification of the bidding documents, which it receives no later than ten (10) days prior to the deadline
for the submission of bids prescribed in the Invitation for Bids. Written copies of the Procuring
Agencys response (including an explanation of the query but without identifying the source of inquiry)
shall be sent to all prospective bidders that have received the bidding documents.
PREPARATION OF BIDS
8.
Language of Bid:
The bid prepared by the bidder, as well as all correspondence and
documents relating to the bid exchanged by the bidder and the Procuring Agency shall be written in
English. Supporting documents and printed literature furnished by the bidder may be in another
language provided they are accompanied by an accurate translation in English, in which case, for
purposes of interpretation of the Bid, the translation shall govern.
9.
Documents Comprising the Bid:
The bid shall comprise the following components:
(a) Bid Form and Price Schedule completed in accordance with instruction to bidders (to be
submitted along with financial proposal);
(b) Documentary evidence established in accordance with instruction to bidders that the bidder is
eligible to bid and is qualified to perform the Contract if its bid is accepted;
(c) Documentary evidence established in accordance with instruction to bidders that the goods to be
supplied by the bidder are eligible goods and conform to the bidding documents; and
(d) Bid Security, if any furnished in accordance with instruction to bidders.

10.
Bid Form & Price Schedule:
The bidder shall complete the Bid Form and an appropriate
Price Schedule furnished in the bidding documents, indicating the goods to be supplied, a brief
description of the goods, their strength, packing, quantity, and prices.
11.
Bid Prices:
i.
The bidder shall indicate on the appropriate Price Schedule the unit prices and total bid
price of the goods, it proposes to supply under the Contract.
ii.
Form of price Schedule is to be filled in very carefully, preferably typed. Any alteration /
correction must be initialed. Every page is to be signed and stamped at the bottom. Serial
number of the quoted item may be marked with red / yellow marker.
iii.
The bidder should quote the prices of goods according to the strength / technical
specifications as provided in the Form of Price Schedule and Technical Specifications. The
specifications of goods, different from the demand of bid enquiry, shall straightway be
rejected.
iv.
The bidder is required to offer competitive price. All prices must include the General Sales
Tax (GST) and other taxes and duties, where applicable. If there is no mention of taxes, the
offered / quoted price shall be considered as inclusive of all prevailing taxes/duties. The
benefit of exemption from or reduction in the GST or other taxes shall be passed on to the
Procuring Agency.
v.
Prices offered should be for the entire quantity demanded; partial quantity offers shall
straightaway be rejected. Conditional offer shall also be considered as non-responsive
bidder.
vi.
While tendering your quotation, the present trend / inflation in the rate of goods and
services in the market should be kept in mind. No request for increase in price due to
market fluctuation in the cost of goods and services shall be entertained.
12.
Bid currencies:Prices shall be quoted in Pak Rupees.
13.
Documents Establishing bidders Eligibility and Qualification

i.
The bidder shall furnish, as part of its technical bid, documents establishing the bidders
eligibility to bid and its qualifications to perform the Contract if its bid is accepted.
ii.
The documentary evidence of the bidders eligibility to bid shall establish to the Procuring
Agencys satisfaction that the bidder, at the time of submission of its bid, is an eligible as
defined under instruction to the bidders
iii.
The documentary evidence (to be submitted along with technical proposal) of the bidders
qualifications to perform the Contract if its bid is accepted shall establish to the Procuring
Agencys satisfaction:
(b) The Sole Agent / Importer shall have to produce letter of authorization from Manufacturer
(Foreign Principal) and in case of Manufacturer, documentary proof including drug
manufacturing license / registration certificate, to the effect that they are the original
manufacturer of the required specifications of goods, shall be provided.
(c) National Tax Number (NTN) and General Sales Tax Number (GST) (if applicable) with
documentary proof shall have to be provided by each bidder in the tender.
(d) The bidder shall submit an affidavit on legal stamp paper of Rs. 100/- that their firm is not
blacklisted on any ground by any Government (Federal/Provincial/District), a local body or
a Public Sector Organization. The bidder shall be debarred from bid on account of
submission of false statement.
(e) The bidder should have minimum one-year experience in the market. Similarly, it is
mandatory that the item to be quoted by the bidder / Manufacturer should have availability
in the market minimum for the last one year. Documentary proof shall have to be provided
in this regard.
(f) The bidder is required to provide with the Technical Proposal, the name of item(s) for
which they have quoted their rates in the Financial Proposals.
(g) The bidder must indicate the registration number, make of country of origin / Manufacturer
of the drugs, capacity of production of the firm, its financial status, batch capacity,
necessary assurance of quality production, GMP / cGMP, and list of qualified technical and
supervisory staff working in the production and quality control departments in the
manufacturing plants.
(h) The bidder shall provide a list of plant, major machinery and equipment installed in the
factory. In case of imported Drugs / Medicines, the profile / credentials of the foreign
Manufacturer in the respective foreign country, shall be provided along with bid.
14.
Documents Establishing Goods Eligibility and Conformity to Bidding Documents:

i.
The bidder shall furnish along with Technical Proposal, as part of its bid, documents
establishing the eligibility and conformity to the bidding documents of all goods, which the
bidder proposes to supply under the Contract.
ii.
The documentary evidence of the eligibility of the goods shall consist of a statement in the
Price Schedule of the country of origin of the goods offered which a certificate of origin
issued by the Manufacturer shall confirm.
iii.
Submission of sample:
a) The bidder must produce along with technical proposal, Two (02) samples of quoted
product(s) (Commercial pack) according to the strength and packing of demand of
enquiry. No technical proposal / bid shall be considered in absence of samples.
b) The representative sample(s) must be from the most recent stocks, supported by valid
warranty as per Drugs Act 1976.
15.
Bid security. The procuring agency may require the bidders to furnish a bid security equal to
2% of total bid value.

16.
Bid validity. (1) A procuring agency, keeping in view the nature of the procurement, shall
subject the bid to a bid validity period.

(2)
The bids shall be valid for the period of 90-days.
(3)
Subject to sub-rule (5), a procuring agency shall ordinarily be under an obligation to process
and evaluate the bids within the stipulated bid validity period but, under exceptional circumstances and
for reasons to be recorded in writing, if an extension is considered necessary, all the bidders shall be
requested to extend their respective bid validity period but such extension shall not be for more than the
original period of bid validity.
(4)
A bidder who:
(a)
agrees to the extension of the bid validity period shall also extend the validity of the bid
bond or security for the extended period of the bid validity;
agrees to the procuring agencys request for extension of bid validity period shall not be
(b)
permitted to change the substance of the bid; and

(c)
does not agree to an extension of the bid validity period shall be allowed to withdraw
the bid without forfeiture of the bid bond or security.
17. Extension of time for submission of bids. If a procuring agency considers that it is necessary in
public interest to extend the last date for the submission of the bids, it may, after recording reasons, do
so in the manner similar to the original advertisement.
18.
Format and Signing of Bid:

i.
The bidder shall prepare and submit its bid along with original purchase receipt. The bid
shall be typed or written in indelible ink and shall be signed by the bidder or a person or
persons duly authorized to bind the bidder to the Contract. The person or persons signing
the bid shall initial all pages of the bid, except for un-amended printed literature.
ii.
Any interlineations, erasures, or overwriting shall be valid only if they are initialed by the
person or persons signing the bid.
SUBMISSION OF BIDS
19.
i.
Sealing and Marking of Bids

The envelopes shall be marked as FINANCIAL PROPOSAL and TECHNICAL
PROPOSAL in bold and legible letters to avoid confusion. The inner and outer envelopes
shall:
a. be addressed to the Procuring Agency at the address given in the Invitation for Bids and;
b. bear the name and number indicated in the Invitation for Bids.
ii.
The inner envelopes shall also indicate the name and address of the bidder to enable the bid to
be returned unopened in case it is declared as non-responsive or late.
iii.
If the outer as well as inner envelope is not sealed and marked as required by instruction to
bidders, the Procuring Agency shall assume no responsibility for the bids misplacement or
premature opening.
20.
Deadline for Submission of Bids:
Bids must be submitted by the bidder and received by
the Procuring Agency at the address specified under instruction to bidders, no later than the time and
date specified in the Invitation for Bids.
21.
Late Bid:
Any bid received by the Procuring Agency after the deadline for submission of
bids prescribed by the Procuring Agency shall be rejected and returned unopened to the bidder
22.
Withdrawal of Bids:
The bidder may withdraw its bid after the bids submission and prior to
the deadline prescribed for submission of bids. No bid may be withdrawn in the interval between the
deadline for submission of bids and the expiration of the period of bid validity specified in instruction to
bidders. Withdrawal of a bid during this interval may result in the Bidders forfeiture of its Bid Security
(Earnest Money), pursuant to the instruction to bidders.
OPENING AND EVALUATION OF BIDS

23.
Opening of Bids
i.
The Procuring Agency shall initially open only the envelopes marked TECHNICAL
PROPOSAL in the presence of bidders representatives who choose to attend, at the time,
on the date, and at the place specified in the Invitation for Bids. The bidders representatives
who are present shall sign the Attendance Sheet evidencing their attendance. However, the
envelope marked as FINANCIAL PROPOSAL shall be retained in the custody of
Procuring Agency without being opened and till completion of the evaluation process.
ii.
The bidders names, item(s) for which they quoted their rate and such other details as the
Procuring Agency, at its discretion, may consider appropriate, shall be announced at the
opening of technical proposal. No bid shall be rejected at technical proposal / bid opening,
except for late bids, which shall be returned unopened to the bidder. However, at the
opening of Financial Proposals (the date, time and venue would be announced later on), the
bid prices, discounts (if any), and the presence or absence of requisite Bid Security and such
other details as the Procuring Agency, at its discretion, may consider appropriate, shall be
announced.
iii.
The financial bids found having without Bid Security (Earnest Money) shall also be
returned unannounced to the bidders; even they qualified in the evaluation of technical
proposal. However, prior to return to the bidder, the Chairman of the Purchase Committee
shall record statement / reason on such bids.
iv.
24.
The Procuring Agency shall prepare minutes of the bids opening (technical and financial).
Clarification of Bids: During evaluation of the bids, the Procuring Agency may, at its
discretion, ask the bidder for a clarification of its bid. The request for clarification and the response shall
be in writing, and no change in the prices or substance of the bid shall be sought, offered, or permitted
25.
Preliminary Examination
i.
The Procuring Agency shall examine the bids to determine whether they are complete,
whether any computational errors have been made, whether required sureties have been
furnished, whether the documents have been properly signed, and whether the bids are
generally in order.
ii.
In the financial bids the arithmetical errors shall be rectified on the following basis. If there
is a discrepancy between the unit price and the total price that is obtained by multiplying the
unit price and quantity, the unit price shall prevail, and the total price shall be corrected. If
the bidder does not accept the correction of the errors, its bid shall be rejected, and its bid
Security may be forfeited. If there is a discrepancy between words and figures, the amount
in words shall prevail.
iii.
The Procuring Agency may waive any minor informality, nonconformity, or irregularity in
a bid which does not constitute a material deviation, provided such waiver does not
prejudice or affect the relative ranking of any bidder.
iv.
Prior to the detailed evaluation, the Procuring Agency shall determine the substantial
responsiveness of each bid to the bidding documents. For purposes of these Clauses, a
substantially responsive bid is one, which conforms to all the terms and conditions of the
bidding documents without material deviations. Deviations from, or objections or
reservations to critical provisions, such as those concerning Applicable Law, Drugs Act,
Taxes & Duties and GMP practices shall be deemed to be a material deviation for technical
proposals and Bid Security for financial proposals. The Procuring Agencys determination
of a bids responsiveness is to be based on the contents of the bid itself without recourse to
extrinsic evidence.
v.
If a bid is not substantially responsive, it shall be rejected by the Procuring Agency and may
not subsequently be made responsive by the bidder by correction of the nonconformity.
26.
Evaluation & Comparison of Bids

i.
The Procuring Agency shall evaluate and compare the bids, which have been determined to
be substantially responsive.
ii.
The Procuring Agencys evaluation of technical proposal / bid shall be on the basis of
previous performances, previous test reports, inspection of plant/ factory / premises (if not
previously conducted), previous experience, financial soundness and such other details as
the Procuring Agency, at its discretion, may consider appropriate, shall be considered.
However, the evaluation of financial proposal shall be on the basis of price inclusive of
prevailing taxes and duties in pursuant to instruction to bidders and bid Security.
iii.
All bids shall be evaluated in accordance with the evaluation criteria and other terms &
conditions set forth in these bidding documents.
iv.
A bid once opened in accordance with the prescribed procedure shall be subject to only
those rules, regulations and policies that are in force at the time of issue of notice for
invitation of bids.
27.
Evaluation Criteria:
For the purposes of determining the lowest evaluated bid, facts other than price such as previous
performances, previous Drugs Testing Laboratory, test / analysis reports, inspection of plant /
factory / premises, previous experience, financial soundness and such other details as the
Procuring Agency, at its discretion, may consider appropriate shall be taken into consideration.
The following merit point system for weighing evaluation factors/ criteria can be applied for the
TECHNICAL PROPOSALS. The number of points allocated to each factor shall be specified
in the Evaluation Report.
EVALUATION CRITERIA FOR GENERAL MEDICINES 2015-16
1
iv.
v.
Physical report
manufacturers Spec
Quality of Printing, Packing / Packaging & Labeling Material
with
15
03
10
vi.
02
Length of registration of relevant product from Ministry of

Health.
10
ii.

20
10
10
10
iii.
iv.
1-10
5
8

Financial Position/status.
Income Tax return/any other proof of Income Tax paid for last two
years.
10
10
05
Market availability of the quoted item at Head Offices of Leading

and Green Plus).
25
v.
20
vi.
25
Percentage of dosage forms approved by prequalification team.
10
iii.
Less than 50%
03
iv.
More than 50% / Less than 100%
05
Iii
7
iii.
100%
10
10
02
iv.
08
iii.
iv.
5
iv.
Total:-
02
05
15
100
Anticancer Medicines shall be evaluated under Clause-5 as per following

details:CLAUSE-5 FOR ANTICANCER MEDICINES.
5.
(i)
(ii)
(iii)
Market availability at pharmacies of Shaukat 25

Khanum, Inmol, Mayo Hospital and Jinnah Hospital
for last one year.
15
20
25
Following Clause-5 shall also be applicable for Hospital Items (Anaesthesia

medicines, Dressing, POP, Cotton Wool, Cotton Gauze, Cotton and Crepe
Bandage):CLAUSE-5 FOR HOSPITAL ITEMS
Anesthesia items, Dressing, Gauze, Cotton Wool, Bandages, Dressing and POP.
5.
(i)
(ii)
(iii)
Supply order from Government Institutions (last one

year)
25
15
20
25
The firms having no past experience with PESSI Head Office shall be
evaluated under clause-3 as per following detail:CLAUSE-3 FOR THE FIRMS HAVING NO PAST EXPERIENCE WITH PESSI
HEAD OFFICE
3.
Past Performance of bidder with Government 20
(i)
(ii)
Institutions and PESSI local tender. (Last 2 years)

Supply
order
of
Government
Hospitals
(1-5 Institutions)
Supply
order
of
Government
Hospitals
(More than 5 Institutions)
Supply orders of Private Hospital / Organization (1-5
Supply Orders)
Supply orders of Private Hospital / Organization (More
than 5 Supply Orders)
05
10
05
10
Note:
4. Any medicine having adverse reaction / poor efficacy reported by the
consultants shall be straightway disqualified and shall not be further evaluated
under the Evaluation Criteria.
regarding the efficacy of any medicines keeping in view their past experience
and decision of the committee regarding qualification / disqualification shall
prevail.
Instructions
page marking.
column.
EVALUATION CRITERIA FOR INTERFERON 2015-16
iii.
iv.
2
ii.
3
iii.
iv.
iii.
Physical report.
Complies with Official Books (BP/USP etc)/Complies with
manufacturers Spec
Length of registration of relevant product from Ministry of Health.
10
05
05
10
1-10
20
10
5

10
10
10

15
More than Five.
15
05
08
iv.
5
iv.
v.
vi.
6
ii.
ii.
7
i.
ii.
8
iii.
iv.
15
More than Five.
Market availability of the quoted item at Head Office of Leading
and Green Plus)
05
07
25
15
20

25
Packing of the quoted item.
10
Ampoule/Vial
05
Pre-filled Syringe.
10
Product Certification.
10
WHO/FDA approved.
05
Dose and efficacy certificate from NIH Islamabad.
05
10
02
08
Total:100
Note:
4. Medicines having adverse reaction / poor efficacy reported by the consultants
shall be straightway disqualified and shall not be further evaluated under the
Evaluation Criteria.
regarding the efficacy of any medicines keeping in view their past experience and
decision of the committee regarding qualification / disqualification shall prevail.
Instructions
page marking.
column.
EVALUATION CRITERIA FOR DISPOSABLE SYRINGES 2015-16

Mandatory Clauses:Product should be registered with M.O.H / DRAP.
In case of imported syringes, the product must be available in the country of
origin and provide Sole Agency Agreement with foreign manufacturer duly
attested by the concerned Pakistan Embassy / High Commission.
Firms should have following certificates
(iv)
ISO 13485, ISO 9001
(v)
CE Mark
(vi)
GMP Certificate (last one year).
1.
2.
3.
General Clauses
1
Physical report
iv. Quality of Printing, Packing / Packaging & Labeling Material

v. Raw Material used is of Medical Grade attach proof/under taking.
vi. Submission of complete Drug Specification proforma.
25
Physical Examination of Syringe by Technical Committee.
10
10
05
25
iii.
iv.
Sharpness of needle.
Plunger positive/negative pressure.
Financial position/status.
13
12
10
iii.
iv.
4
iii.
iv.
5
iv.
v.
vi.
Income Tax Return/any other Proof of Income Tax paid for last one
year.
15
More than Five.
05
03
05
15
05
08
05
15
More than Five.
07
Market Availability of the quoted items at Head Office of Leading
25
and Green Plus)
15
20
25
Total:100
Note:
i.
Minimum qualifying marks 70/100.
ii.
Medicines qualifying 70% marks shall be presented before
the Technical Committee comprising of Specialists of PESSI

Hospitals for their reservation regarding the efficacy of any
medicines keeping in view their past experience and decision of the
committee regarding qualification / disqualification shall prevail.
Instructions
page marking.
column.
ANOUNCEMENT
i)
After completion of technical evaluation, the technical status shall be announced
amongst the successful as well as unsuccessful bidders by the Procuring Agency.
The financial proposals shall be returned unopened to unsuccessful bidders after
completing the selection process. The Procuring Agency shall simultaneously
notify in writing bidders that have secured the minimum qualifying marks, the date,
time and location for opening the financial proposals. bidders attendance at the
opening of financial proposals is optional.
ii)
Financial proposals shall be opened publicly in the presence of the bidders

representatives who choose to attend. The name of the bidders and the technical
score of the bidder shall be read aloud. The financial proposal of the bidders who
met the minimum qualifying marks shall then be inspected to confirm that they
have remained sealed and unopened. These financial proposals shall be then opened
and the quoted price read aloud and recorded.
28
Contacting the Procuring Agency:
No bidder shall contact the Procuring Agency on any
matter relating to its bid, from the time of the bid opening to the time the Contract is awarded. If the
bidder wishes to bring additional information to the notice of the Procuring Agency, it should do so in
writing. Any effort by a bidder to influence the Procuring Agency in its decisions on bid evaluation, bid
comparison, or Contract award may result in the rejection of the bidders bid. Canvassing by any bidder
at any stage of the Tender evaluation is strictly prohibited. Any infringement shall lead to
disqualification.
29.
Qualification & disqualification of bidders:
In
the
absence
of
prequalification,
the
Procuring Agency shall reject the bid. The Procuring Agency shall disqualify a bidder if it finds, at any
time, that the information submitted by him concerning his qualification was false and materially
inaccurate or incomplete.
30. Rejection of bids. (1) The procuring agency may reject all bids or proposals at any time prior to
the acceptance of a bid or proposal.
(2) The procuring agency shall upon request communicate to any bidder, the grounds for its rejection of
all bids or proposals, but shall not be required to justify those grounds.
(3) The procuring agency shall incur no liability, solely by virtue of its invoking sub-rule (1) towards the
bidders.
(4) The bidders shall be promptly informed about the rejection of the bids, if any.
31. Re-bidding. If the procuring agency rejects all the bids under rule 35, it may proceed with the
process of fresh bidding but before doing that it shall assess the reasons for rejection and may, if
necessary, revise specifications, evaluation criteria or any other condition for bidders.
32. Announcement of evaluation reports. A procuring agency shall announce the results of bid
valuation in the form of a report giving justification for acceptance or rejection of bids at least ten days
prior to the award of procurement contract.
AWARD OF CONTRACT
33.
Acceptance of Bid and Award criteria

The bidder with the lowest evaluated bid, if not in conflict with any other law, rules, regulations
or policy of the Provincial Government, shall be awarded the Contract, within the original or extended
period of bid validity.
34
Procuring Agencys right to vary quantities at time of award

The Procuring Agency reserves the right to increase or decrease, the quantity of goods
originally specified in the Price schedule and Schedule of Requirements without any change in unit
price or other terms and conditions.
35
Negotiations
PPRA Rules 2014 shall be followed.
36.
Notification of Award
i.
Prior to the expiration of the period of bid validity, the Procuring Agency shall notify
the successful bidder in writing by registered letter, that its bid has been accepted.
ii.
37
The notification of award shall constitute the formation of the Contract.
Signing of Contract
i.
At the same time as the Procuring Agency notifies the successful bidder that its bid has
been accepted, the Procuring Agency shall send the bidder the Contract Form provided
in the bidding documents, incorporating all agreements between the Parties.
ii.
Both the successful bidder and the Procuring Agency shall sign with date the Contract
on the legal stamp paper worth Rs100/. Thereafter, the Procuring Agency shall issue
Purchase Order. If the successful bidder, after completion of all Codal Formalities
shows inability to sign the Contract then their Bid Security shall be forfeited and the
firm shall be blacklisted minimum for two years. In such situation, the Procuring
Agency may make the award to the next lowest evaluated bidder.
38.
Performance Security.
i.
On the date of signing of Contract, the successful bidder shall furnish the Performance
Security (7% of total order value) in accordance with the Conditions of Contract,
provided in the bidding documents. The 2% bid Security would be returned to the
bidder upon submission of Performance Security.
ii.
Failure of the successful bidder to comply with the requirement of instructions to the
bidders shall constitute sufficient grounds for the annulment/termination of the award
and forfeiture of the bid Security, in which event the Procuring Agency may make the
award to the next lowest evaluated bidder.
39.
Blacklisting
PPRA Rules 2014 shall be followed
GENERAL CONDITIONS OF CONTRACT

1.
Definitions:
In this Contract, the following terms shall be interpreted as indicated against
each.
a.
The Contract means the agreement between the Procuring Agency and the Supplier, as
recorded in the Contract Form signed by the Parties, including all attachments and
appendices thereto and all documents incorporated by reference therein.
b. The Contract Price means the price payable to the Supplier under the Contract for the
full and proper performance of its contractual obligations. Price reasonability certificate that
the prices quoted are not more than the prices quoted in Health Department Govt. of the
Punjab/ any other organization.
The rates quoted should not be more than the trade price of the respective item.
c. The Goods means drug/ medicines which the Supplier is required to supply to the
Procuring Agency under the Contract.
d. The Specifications means the specifications of medicines, the offered items should be
consistent with the specifications.
e. The Services means those services ancillary to the supply of goods, such as printing of
special instructions on the label and packing, design, logo, transportation upto CMSD,
Defence Road, Lahore and at consignee end in case of supply of Inj. Interferon and other
such obligations of the Supplier covered under the Contract.
f.
The Procuring Agency: is the Punjab Employees Social Security Institution and other
PESSI Hospitals / PESSI Directorates under the administrative control of PESSI.
g. The Consignee
means Director Medical, In charge, Central Medical Store Depot,
Defence Road, Lahore, for the supply order issued for medicines by the Head Office and
Medical Superintendents for the supply of Inj. Interferon.
h. The Supplier means the individual or firm supplying the goods under this Contract.
Eligible Bidder
2.
The tenders are to be quoted by the firm pre-qualified with PESSI only for
the approved dosage form. Copy of the valid pre-qualification letter is to be attached with the tender,
failing which the offers will be rejected.
3.
Application:
These General Conditions shall apply to the extent that they are not inconsistent
/ superseded by provisions of other parts of the Contract

4.
Standards:
The goods supplied under this Contract shall conform to the standards
mentioned in the Technical Specifications.

5.
Pack adjustment Pack adjustment of the medicines if required will be made by PESSI.
6.
Submission of Samples:
Labeling and Packing of the product would be examined in
accordance with Labeling and Packing Rules 1986 of the Drugs Act 1976. The Supplier shall provide
TWO (02) samples (commercial packs); free of cost along with the tender failing which the offers will
not be accepted.
7.
Ensuring intimation of storage arrangements: To ensure storage arrangements for the
intended supplies, the Supplier shall inform the Consignee one week in advance.
8.
Inspections and Test / Analysis

i)
The Procuring Agency or its representative shall have the right to inspect and /or to test the
goods to confirm their conformity to the specifications of the contract at no extra cost to the
Procuring Agency.
ii)
The inspection committee constituted by PESSI, Head Office shall inspect the quantity and
specifications of medicines who will submit a report on Inspection Certificate.
iii)
The supplier will be responsible for free replacement of stocks if the same is not found to
be of the same specifications as required in the Invitation of Bids / Substandard /Spurious /
Misbranded / Expired. Moreover, it will replace the unconsumed expired stores without any
further charges.
The Procuring Agencys right to inspect, test and, where necessary, reject the goods after
iv)
the arrival at Procuring Agencys destinations shall in no way be limited or waived by

reason of the goods having previously been inspected, tested, and passed by the Procuring
Agency or its representative.
v)
Nothing in General Conditions of Contract shall in any way release the Supplier from any
warranty or other obligations under this Contract.
9.
Chemical and physical examination of medicines

I
All the Drugs / Medicines shall be acceptable subject to chemical and physical
examination. The chemical examination shall be carried out through the Drugs Testing Laboratory
Government of Punjab. If the facility for test / analysis is not available with DTL, Government of
Punjab then the sample will be sent to NIH, Islamabad. If the test facilities are not available with the
DTL, Government of Punjab as well as NIH Islamabad then the batch release certificate and test
analysis report of quality control / quality assurance department of the manufacturer shall be relied
upon.
II
The Inspection Committee constituted by PESSI, Head Office shall carry out the
physical examination after receipt of supplies. If the medicines supplied are found during physical
examination / inspection to be against the required specifications, approved samples, etc, even if it is of
standard quality, the Procuring Agency may reject the goods, and the Supplier shall either replace the
rejected goods or arrange alterations necessary for rectification of observation, to meet the required
specifications free of cost. Replacement in lieu of the rejected supplies must be completed within 15
days from the date of communication of decision to the Manufacturer / Supplier by the Concerned
Authority. In case after replacement or alteration, the Inspection Committee again declare the item as of
against the required specifications, the supply would completely be rejected and the proportionate
amount of performance security of the concerned installment would be forfeited to the PESSI account
and the firm shall be blacklisted minimum for one year. However, if the entire supplies/ installments are
declared as of against the required specifications, the entire performance security shall be forfeited and
the firm shall be blacklisted minimum for two years.
10.
Delivery and Documents:
Any erasing/cutting/crossing etc. appearing in the offer must be
properly signed by the person signing the tender. Moreover all pages of the tender must be signed. Offer
with any over writing in no circumstances shall be accepted. The Supplier in accordance with the terms
specified in the Bidding Documents shall make delivery of the goods. The details of documents to be
furnished by the Supplier are specified in Special Conditions of the Contract.
11.
Insurance/Income Tax etc. Octroi/Income Tax and all other Government charges will be paid
by the supplier.
12.
Transportation:
The Supplier shall arrange such transportation / cold chain maintenance of
the goods as is required to prevent their damage or deterioration. The medicines shall be delivered at
CMSD Defence Road, Lahore. In case of any subsequent/supplementary order from S.S.
Hospitals/Directorates, the supplier shall be responsible for the delivery at consignee end. All taxes shall
be borne by the Supplier. Transportation including loading / unloading of goods shall be arranged and
paid for by the Supplier
13.
Storage: The cold chain maintenance of heat sensitive products i. Inj. Interferon shall be the
responsibility of the bidder.

14.
Incidental Services:
The Supplier shall be required to provide the incidental services as
specified in Special Conditions of the Contract and the cost of which should include in the total bid
price.
15.
Warranty Certificate: The Drugs / Medicines shall be accompanied by the necessary warranty
(on judicial paper) in accordance with the provision of the Drugs Act, 1976 and rules framed there
under. The Procuring Agency shall promptly notify the Supplier in writing of any claims arising under
this warranty.
16.
Payment:
The method and conditions of payment to be made to the Supplier under this
Contract shall be specified in Special Conditions of the Contract. The currency of payment is Pak.
Rupees.
Payment will be made by the Commissioner against bill to be submitted by the contracting firms duly
supported with the inspection certificate and test reports. For imported items Bill Of Entry is also to be
provided to the inspection team otherwise inspection will not be conducted to proceed further
accordingly.
17.
Prices: Prices charged by the Supplier for goods delivered under the Contract shall not vary
from the prices quoted by the Supplier in its bid and shall remain the same till expiry of the original bid
validity period provided the Procuring Agencys request for bid validity extension.
18.
Contract Amendments:
No variation in or modification of the terms of the Contract
shall be made except by written amendment signed by the Parties.

19.
Subcontracts: The Supplier shall not be allowed to sublet the job and award subcontracts
under this Contract.

20.
Delays in the Suppliers Performance: Delivery of the goods shall be made by the Supplier in
accordance with the time schedule prescribed by the Procuring Agency. If at any time during
performance of the Contract, the Supplier should encounter conditions impeding timely delivery of the
goods, the Supplier shall promptly notify the Procuring Agency in writing of the fact of the delay, its
likely duration and its cause(s). The Procuring Agency may at its discretion extend the Suppliers time
for performance, with liquidated damages, in which case the extension shall be ratified by the Procuring
Agency. A delay by the Supplier in the performance of its delivery obligations shall render the Supplier
liable to the imposition of liquidated damages, unless an extension of time is agreed upon without the
application of liquidated damages.
21.
Penalties/liquidated Damages: In case of late delivery beyond the stipulated period, penalty as
specified in Special Conditions of Contract shall be imposed upon the Supplier. The above Late
Delivery (LD) is subject to General Conditions of Contract including late delivery for reasons beyond
control. Once the maximum is reached, the Procuring Agency may consider termination of the Contract.
In case of supply of substandard product the destruction cost will be borne by the firm i.e. burning,
Dumping, Incineration. If the firm provides substandard item and fail to provide the item the payment of
risk purchase (which will be purchased by the Consignee) the price difference shall be paid by the Firm.
Broken and damaged material will be replaced by the supplier free of cost.
22.
Termination for Default:
The Procuring Agency, without prejudice to any other remedy for
breach of Contract, by written notice of default sent to the Supplier, may terminate the Contract in
whole or in part, if the Supplier fails to deliver any or all installments of the goods within the period(s)
specified in the Contract, or within any extension thereof granted by the Procuring Agency; or if the
Supplier fails to perform any other obligation(s) under the Contract and if the Supplier, in the judgment
of the Procuring Agency has engaged in corrupt or fraudulent practices in competing for or in executing
the Contract
23.
Force Majeure
Notwithstanding the provisions of general conditions of contract the Supplier shall not be liable
for forfeiture of its Performance Guaranty/ bid Security, or termination/ blacklisting for default if and to
the extent that its delay in performance or other failure to perform its obligations under the Contract is
the result of an event of Force Majeure. For the purposes of this clause Force Majeure means an act of
God or an event beyond the control of the Supplier and not involving the Suppliers fault or negligence
directly or indirectly purporting to mis planning, mismanagement and/or lack of foresight to handle the
situation. Such events may include but are not restricted to acts of the Procuring Agency in its sovereign
capacity, wars or revolutions, fires, floods, earthquakes, strikes, epidemics, quarantine restrictions and
freight embargos. If a Force Majeure situation arises, the Supplier shall promptly notify the Procuring
Agency in writing with sufficient and valid evidence of such condition and the cause thereof. The
Committee constituted by PESSI, Head Office for Redressal of grievances, shall examine the pros and
cons of the case and all reasonable alternative means for completion of purchase order under the
Contract and shall submit its recommendations to the competent authority. However, unless otherwise
directed by the Procuring Agency in writing, the Supplier shall continue to perform its obligations under
the Contract as far as is reasonably practical and shall seek reasonable alternative means for
performance not prevented by the Force Majeure event.
24.
Termination for Insolvency

The Procuring Agency may at any time terminate the Contract by giving written notice of one
month time to the Supplier if the Supplier becomes bankrupt or otherwise insolvent. In this event,
termination shall be without compensation to the Supplier, provided that such termination shall not
prejudice or affect any right of action or remedy which has accrued or shall accrue thereafter to the
Parties.
25.
Arbitration and Resolution of Disputes:
The Procuring Agency and the Supplier shall
make every effort to resolve amicably by direct informal negotiation any disagreement or dispute arising
between them under or in connection with the Contract. If, after thirty (30) days from the
commencement of such informal negotiations, the Procuring Agency and the Supplier have been unable
to resolve amicably a Contract dispute, either party may require that the dispute be referred to the
Arbitrator for resolution through arbitration. In case of any dispute concerning the interpretation and/or
application of this Contract shall be settled through arbitration. The Commissioner, PESSI or his
nominee shall act as sole arbitrator. The decisions taken and/or award made by the sole arbitrator shall
be final and binding on the Parties
26.
Governing Language: The Contract shall be written in English language. All correspondence
and other documents pertaining to the Contract, which are exchanged by the Parties, shall be written in
English.
27.
Applicable Law
This contract shall be governed by the laws of Pakistan and the courts of Pakistan shall have
exclusive jurisdiction.
28. Notices
1
Any Notice given by one party to the other pursuant to this contract shall be sent to the
other party in writing and confirmed to other partys address specified in Special
Conditions of Contract.
A notice shall be effective when delivered or on the notices effective date, whichever is
later
SPECIAL CONDITION OF CONTRACT

1.
Definitions;
i. The Procuring Agency: is the Punjab Employees Social Security Institution and other
Institutions under administrative control of PESSI, Head Office i.e. PESSI, Hospitals/PESSI,
Directorates. PESSI reserves the right to purchase full or part of the stores or
ignore/scrape/cancel the tender without assigning reasons.
ii. The Supplier; is the individual or firm supplying the goods under this contract.
2.
Availability: All medicines supplied to PESSI should be freely available at Head Offices of
leading chain Pharmacies of Lahore, if not so the offer of the firm would be cancelled (Bill
warranties for last one year should be attached).
3.
Bid Security;
The bidder shall furnish, as part of its financial proposal / bid, the Bid Securities / Earnest
Money (refundable) in Pak Rupees @ 2% of the total bid value in the shape of Bank Draft, Pay Order or
Call Deposit in the name COMMISSIONER PESSI. The financial bid found deficient of the bid
Security shall not be considered. No personal cheque shall be acceptable. The previous bid Security (if
any), if available, shall not be considered or carried forward. However, the bid security of any
successful bidder shall be returned upon submission of Performance Security and in case of
unsuccessful bidder, the bid security of the bidder shall be returned.
4.
Performance Security
After signing of contract, the successful bidders shall have to deposit bank draft of the amount
equal to 7% of order value as performance security in shape of deposit at call, for each phase. The bid
Security will be returned to the bidder upon submission of Performance Guaranty/Security.
5.
Inspection.
Inspection and tests of drugs / medicine at final acceptance shall be in accordance with the
conditions of contract. After delivery at CMSD Defence Road, Lahore, the goods shall be
inspected/examined by the Inspection Committee, to physically check the goods in accordance with the
approved sample and terms / conditions of the Contract. The Committee shall submit its inspection
report to PESSI, Head Office, Lahore. In case of any deficiency, pointed out by the Inspection
Committee in the delivered medicines the Supplier shall be bound to rectify it free of cost. For imported
items Bill Of Entry is also to be provided to the inspection team otherwise inspection will not be
conducted to proceed further accordingly.
6.
Testing.
The samples shall be collected for analysis and send to DTL, Punjab. The samples drawn for
Drug Testing are to be replaced by the firm at the time of supply as per rules failing which PESSI will
not be responsible for delay in payment. Testing charges of samples against the supplies will be borne
by the supplying firms irrespective of the result of sample.
A certificate should be furnished by the tenderers that they will be responsible for the free
provision of new stores if the same are found to be substandard or at variance with the specifications
give in the tender inquiry. Stores of a specifications superior to the one specified in the tender inquiry
shall, however, be considered.
If the stores are declared sub-standard by DTL Punjab / NIH Islamabad, distribution shall not be
carried out and the entire stock will be confiscated and destroyed and the firm shall replace the whole
stock with the fresh stock free of cost. The procuring agency may take any other punitive action
including forfeiture of performance security and blacklisting.
7.
Delivery and Documents.

The supply order will be placed for the period from July, 2015 to 30th June, 2016. The supply
period will be 30 days from the date of issue of supply order with a grace period of 10-days which will
start immediately after expiry of 30-days time. Any subsequent/supplementary order placed by the Head
Office/Directorates/S.S. Hospitals, shall also be complied with by the firm promptly, on the same rates
as quoted/& approved by the Head Office PESSI. The Supplier shall provide the following documents at
the time of delivery of goods to Consignee end for verification and onward submission to quarter
concerned, duly completed in all respect for payment.
(i)
Original copies of Delivery Note / Challan (in duplicate)in the name of In charge
Director Medical CMSD, Defence Road, Lahore and Medical Superintendent PESSI
Hospitals where delivery is to be made, items description, batch No(s), Registration
No, manufacturing and expiry date and quantity.
Original copies of the Suppliers invoices (in duplicate) showing warranty, in the name
(ii)
of Commissioner PESSI, Head Office, items description, Batch No, Registration No,
manufacturing and expiry date, quantity, per unit cost, and total amount.
(iii)
Attested copies of valid drug manufacturing & sale license, Pre-qualification letter with
PESSI & drugs registration certificates shall be attached. The firm will have to provide
the valid professional tax exemption certificate.
(iv)
NTN Certificate.
(v)
Undertaking on judicial paper.
(vi)
Receipt of (F-6), 7% of order value.
(vii)
Three copies of the latest printed Original Price List should be attached.
(viii)
The firms providing false documents or giving misleading statements will be debarred
from the current & next tenders.
(ix)
Valid letter of authorization from the Foreign Principal in case of Sole Agent /
Importer.
8.
Incidental Services
The following incidental services shall be provided and the cost of which should include in the
total bid price.

a.
The bidder shall supply drugs/medicines as far as possible as per tender requirement in
commercial packing with Logo of PESSI.
b. The following wording/insignia shall be printed in bold letters (English) on each carton,
pack, bottle, strip / blister, tubes, vial / ampoule etc.
PESSI PROPERTY NOT FOR SALE
c. The rules for labeling and packing shall be followed as per The Drugs (Labeling and
Packing) Rules, 1986, framed under the Drugs Act, 1976. However, the name of Drug /
Medicine (Generic & Brand), equally prominent, should be printed/ written in indelible ink
in English on the outer cartons and on each Pack, Bottle, Strip/ Blister, Tubes etc. Besides
the name and principal place of business of the Manufacturer, the drug manufacturing license
No., manufacturing date, expiry date, registration No., batch No., retail price, and Urdu
version namely, name of drug, dosage and instructions, should also be written on the outer
carton and on the most inner container in bold letters. All tablets shall be supplied in
aluminium strip / blister pack. Expiry date must be printed on each aluminium strip /
blister. The syrup should be supplied in glass / pet bottle with sealed caps as per sample
provided at the time of opening of tender. 2ml and less than 2ml ampoules, heat sensitive
ampoules and water for injection / distilled water supplied alongwith antibiotic & powder
vials shall be exempted from over printing however outer cartons and master cartons shall be
printed as PESSI Property not for Sale. In case of non fulfillment of these requirements the
supply shall not be accepted.
d. Glass ampoules having no paper label shall be exempted from printing from PESSI
PROPERTY NOT FOR SALE, however, outer carton or master carton shall be printed as
PESSI PROPERTY NOT FOR SALE.
e. In case of ampoules which are packed in tray, PESSI PROPERTY NOT FOR SALE shall
be printed on the label of the tray and ampoules may be exempted from printing PESSI
PROPERTY NOT FOR SALE, however, outer carton or master carton shall be printed as
PESSI PROPERTY NOT FOR SALE.
f.
Kleen Enema bottle shall be exempted from printing PESSI PROPERTY NOT FOR
SALE, however, the plastic cover and outer carton should be printed as PESSI
PROPERTY NOT FOR SALE.
g. Medicines with minimum of 80% shelf life for the locally manufactured shall be accepted
at the time of delivery.
h. Medicines with minimum of 80% shelf life for imported medicines shall be accepted,
however shelf life upto 75% shall be accepted with penalty equal to 1% of total value of the
medicine per percentage point of the short fall in the prescribed shelf life.
i.
If the Supplier / bidder charged the prices of incidental services separately in the financial
bid and not included in the Contract price of goods, the same shall be included prior to
comparison of rates with the other bidders.
9.
Warranty: The drugs/medicines shall be accompanied by the necessary warranty on judicial
under taking in accordance with the provision of the Drugs Act, 1976 / rules framed there under.
10.
Payment
a) The Payment shall be in Pak Rupees.
b) The payment will be made in two parts for Phase I & Phase-II respectively on
submission of documents along with DTL reports and Physical Inspection report
carried out by the committee.
c) The laboratory test / analysis charges of sample either from DTL, Punjab or from NIH,
Islamabad. shall be borne by the Supplier.
11.
Penalties/ Liquidated Damages.

a.
In case where the deliveries as per contract are not completed within the time frame
specified in the schedule of requirement, the Contract to the extent of non-delivered portion of
supply may be cancelled followed by a Show Cause Notice and amount of Performance
Guaranty to the extent of nondelivered portion of supplies of relevant item shall be forfeited
and firm may be blacklisted minimum for a period of one year. If the firm fails to supply the
whole installments, the entire amount of Performance Guaranty/ Security shall be forfeited to
the PESSI account and the firm may be blacklisted minimum for a period of two year.
Institution reserves the right to purchase the item from the IInd-lowest firm at the risk and cost
of the defaulting firm.
b.
Any order placed erroneously shall have to be lifted back by the firm at its own cost.
c.
The delivery period given by PESSI shall be acceptable to the firms. In case of late
delivery of goods beyond the periods specified in the schedule of requirements, penalty @ 1%
per week of the cost of late delivered supply shall be imposed upon the Supplier.
12.
Arbitration and Resolution of Disputes: In case of any dispute, concerning the interpretation and / or application of this Contract shall be
settled through arbitration. The Commissioner, PESSI or his nominee shall act as sole ARBITRATOR.
The decisions taken and/or award made by the sole arbitrator shall be final and binding on the Parties.
13.
Governing Language: The language of this Contract shall be in English.
14.
Applicable Law: This Contract shall be governed by the laws of Pakistan and the courts of
Pakistan shall have exclusive jurisdiction.
15.
Notices
Suppliers address for notice purpose
------------------------------------------------
Procuring Agencys address

for notice purposes shall be the;
-------------------------------------------------The Director (Purchase),

PESSI, Head Office,
Note:
All assessments and procuring procedures i.e. receiving, opening and awarding etc. shall be
governed by the Punjab Procurement Rules 2014.
MANUFACTURERS AUTHORIZATION FORM
To:
The Commissioner,
PESSI.
WHEREAS M/s.________________________________________ who are established and
reputable Manufacturers of medicines having factory located at ________________________do hereby
authorize _________________________________ to submit a bid, and subsequently negotiate and sign
the Contract with you against No.__________________ for the goods manufactured by the firm. We
hereby extend our full guarantee and warranty as per Clause _____ of the General Conditions of
Contract for the goods offered for supply by the above firm against this Invitation for Bids.
{Signature on behalf of manufacturer___________________________}
Note: This letter of authority should be on the letterhead of the Manufacturer and should be
signed by a person competent and having the power of attorney to bind the Manufacturer. It
should be included by the bidder in its bid.
CONTRACT FORM
THIS CONTRACT is made at ---------------------------------on--------------------------day of--------------- 200--, between PESSI (hereinafter referred to as the Procuring Agency) of the First Part; and
M/s------------------------------------- a firm registered under the laws of Pakistan and having its registered
office at ------------------------------------------------------------------------------------------------ (hereinafter
called the Supplier) of the Second Part (hereinafter referred to individually as Party and collectively
as the Parties).
WHEREAS the Procuring Agency invited bids for procurement of medicines in pursuance
where of M/s ---------------------------------------------------------------- being the Manufacturer/ Sole Agent
of items (list enclosed) in Pakistan and ancillary services offered to supply the required item (s); and
Whereas the Procuring Agency has accepted the bid by the Supplier for the supply of item, along with
cost per unit list enclosed.
NOW THIS CONTRACT WITNESSETH AS FOLLOWS:
1.
In this Contract words and expressions shall have the same meanings as are respectively
assigned to them in the General/ Special Conditions of this Contract hereinafter referred to as
Contract:
2.
The following documents shall be deemed to form and be read and construed as integral part of
this Contract, viz:a.

b.
c.
d.
e.
f.
3.
Price Schedule submitted by the bidder,

Technical Specifications;
General Conditions of Contract;
Special Conditions of Contract; and
Procuring Agencys Award of contract; and
Purchase Order
In consideration of the payments to be made by the Procuring Agency to the Supplier as
hereinafter mentioned, the Supplier hereby covenants with the Procuring Agency to provide the Goods
and Services and to remedy defects therein in conformity in all respects with the provisions of this
Contract.
4.
The Procuring Agency hereby covenants to pay the Supplier in consideration of the provision of
the Goods and Services and the remedying of defects therein, the Contract Price or such other sum as
may become payable under the provisions of this Contract at the time and in the manner prescribed by
this Contract.
5.
M/s. ______________________ hereby declares that it has not obtained or induced the
procurement of any Contract, right, interest, privilege or other obligation or benefit from PESSI or any
administrative subdivision or agency thereof or any other entity owned or controlled by it PESSI
through any corrupt business practice.
6.
Without limiting the generality of the foregoing, [the Seller/ Supplier] represents and warrants
that it has fully declared the brokerage, commission, fees etc, paid or payable to anyone and not given or
agreed to give and shall not give or agree to give to anyone within or outside Pakistan either directly or
indirectly through any natural or juridical person, including its affiliate, agent, associate, broker,
consultant, director, promoter, shareholder, sponsor or subsidiary, any commission, gratification, bribe,
finders fee or kickback, whether described as consultation fee or otherwise, with the object of obtaining
or including the procurement of a Contract, right interest, privilege or other obligation or benefit in
whatsoever form from PESSI, except that which has been expressly declared pursuant hereto.
7.
M/s. ________________ certifies that has made and shall make full disclosure of all agreements
and arrangements with all persons in respect of or related to the transaction with PESSI and has not
taken any action or shall not take any action to circumvent the above declaration, representation or
warranty.
8.
M/s. _______________________________ accepts full responsibility and strict liability for
making any false declaration, not making full disclosure, misrepresenting facts or taking any action
likely to defeat the purpose of this declaration, representation and warranty. It agrees that any Contract,
right, interest, privilege or other obligation or benefit obtained or procured as aforesaid shall, without
prejudice to any other right and remedies available to Procuring Agency under any law, Contract or
other instrument, be void able at the option of Procuring Agency.
9.
Notwithstanding any rights and remedies exercised by Procuring Agency in this regard,
M/s.
____________________________ agrees to indemnify Procuring Agency for any loss or damage

incurred by it on account of its corrupt business practices and further pay compensation to Procuring
Agency in an amount equivalent to ten time the sum of any commission, gratification, bribe, finders fee
or kickback given by M/s. ________________ as aforesaid for the purpose of obtaining or inducing the
procurement of any Contract, right, interest, privilege or other obligation or benefit in whatsoever form
from Procuring Agency.
10
In case of any dispute concerning the interpretation and/or application of this Contract shall be
settled through arbitration. Commissioner, PESSI or his nominee shall act as sole arbitrator. The
decisions taken and/or award made by the sole arbitrator shall be final and binding on the Parties.
11.
This Contract shall be governed by the laws of Pakistan and the courts of Pakistan shall have
exclusive jurisdiction.
12.
If the firms provide substandard item and fail to provide the item the payment of risk purchase,
the price difference shall be paid by the Firm

13.
Incase of supply of substandard product the destruction cost will be borne by the firm i.e
burning, Dumping, Incineration

14.
If the price quoted by the firm to the PESSI or more than the prices charged from any other
private/government institution/hospital in the country for the same financial year and in case of any
discrepancy then the firm shall be bound to refund the prices charged in excess. Affidavit to this effect
is also enclosed with the contract by the firm.
IN WITNESS Whereof the Parties hereto have caused this Contract to be executed at PESSI,
Head Office and shall enter into force on the day, month and year first above mentioned.
Signed/ Sealed by the Manufacturer/ Signed/ Sealed by Procuring Agency

authorized Person
1 ________________________________
_________________________________
DIRECTOR (PURCHASE)
PESSI, HEAD OFFICE
2 __________________________________
BID FORM
Date: ___________
No. ____________
To:
The Commissioner,
PESSI, Head Office,
3/A, Gulberg-V,
Lahore.
Having examined the Bidding Documents, the receipt of which is hereby duly acknowledged,
we, the undersigned, offer the supply and deliver the goods specified in and in conformity with the said
Bidding
Documents
for
the
sum
of
[Total
Bid
Amount
________________________], [Bid Amount in words_____________________________________] or

such other sums as may be ascertained in accordance with the Schedule of Prices attached herewith and
made part of this bid.
We undertake, if our bid is accepted, to deliver the goods in accordance with the delivery
schedule specified in the Schedule of Requirements. If our bid is accepted, we shall submit 7% as
performance security (in shape of bank draft) of the contract price.
We agree to abide by this bid for a period of 90 days from the date fixed for bid opening under
instruction to the bidders, and it shall remain binding upon us and may be accepted at any time before
the expiration of that period. Until a formal Contract is prepared and executed, this bid, together with
your written acceptance thereof and your notification of award shall constitute a binding Contract
between us.
We understand that the Procuring Agency is not bound to accept the lowest or any bid,
Procuring Agency may receive.
Name and address of bidder ---------------------------
Dated this ________________day of _____________________________20_____.

Signature (in the capacity of)
Duly authorized to sign bid for and on behalf of.
=====================================================================
DRUG SPECIFICATION PROFORMA

To,
Tender No:
Name of Bidder:
Address:
Phone No.
The Commissioner
Punjab Employees Social Seucrity Institution
(Head Office) 3-A, GulbergV,
Lahore
.
Sr #
PESS
I#
Name of
item as
in PESSI
List
Brand
Name
of the
offered
item
Name of
Manufactur
er
Drug
Registratio
n No
Validit
y of
Drug
Regn
Validity of Licence
Product
confirms to
USP or BP or
manufacturer'
s
specifications
Batch
Capacit
y
Packing
Designe
(Govt/
Commerci
al
Shelf Life
Signature of Authorized Person:

iii)
Fax No.
Drug Mfg/Drug Sales Licence No:
1
2
3
4
5
6
7
8
9
10
NOTE
i)
Due on:
Quoted item should be highlighted with yellow highlighter on drug registration

certificate
and invoices / bill
warranty.
The firm should provide Two (02) commercial packs as representative of the
supplies.
Page No. /
Location of
Drug
Registratio
n letter
Page No. / Location of Bill

Warranty
Fazal
Din
Phara
m Plus
Gree
n
Plus
Clini
x
Servai
d
Designation of Authorized
Person:
Stamp:

(Medicines) Complete

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

(Medicines) Complete

Uploaded by

Copyright:

Available Formats

THE PUNJAB EMPLOYEES' SOCIAL SECURITY INSTITUTION

Rs. 1000/- (Non-refundable)

LAST DATE OF RECEIPT:

30.03.2015 ( 10.30 A.M.)

30.03.2015 ( 11.00 A.M.)

PURCHASE OF MEDICINES, INJECTION INTERFERON AND DISPOSABLE

Fazal Din Pharma Plus.

VERIFIED BY THE AUTHORIZED

Name of Authorized Person:

Designation of Authorized Person:

Participating Firm Name:

Signature of Authorized Person. ____________________________________________

Designation of Authorized Person:

Participating Firm Name:

EVALUATION CRITERIA FOR GENERAL MEDICINES 2015-16

Submission of complete Drug Specification proforma

Length of registration of relevant product from Ministry of

1 10 years (1 mark for each year)

Past Performance of bidder with PESSI. (Last 2 years)

Execution of Supply Order 100%

Compliance to Supply Order from PESSI outlets

Execution of Supply Order 50%

Execution of Supply Order 100%

Market availability of the quoted item at Head Offices of Leading

Availability of quoted item at three Pharmacies

Availability of quoted item at Four Pharmacies

Percentage of dosage forms approved by prequalification team.

Less than 50%

More than 50% / Less than 100%

GMP Certification issued by Ministry of Health.

Anticancer Medicines shall be evaluated under Clause-5 as per following

Market availability at pharmacies of Shaukat 25

Following Clause-5 shall also be applicable for Hospital Items (Anaesthesia

Supply order from Government Institutions (last one

EVALUATION CRITERIA FOR INTERFERON 2015-16

Length of registration of relevant product from Ministry of Health.

1 10 years (1 mark for each year)

Past Performance of bidder with PESSI. (Last 2 years)

Execution of Supply Order 100%

Execution of Supply Order 50%

Execution of Supply Order 100%

Detail of supply in public/private organizations (last one year)

Availability of quoted item at Four Pharmacies

Packing of the quoted item.

2. Invoices / Bill Warranties of respective pharmacies should have page marking

i. Quality of Printing, Packing / Packaging & Labeling Material

Physical Examination of Syringe by Technical Committee.

Technical Committee comprising of Specialists of PESSI Hospitals

Bid Reference No:

Check List (Mandatory) for Documentary Evidence

Latest price list

I/We, the undersigned solemnly state that:

THE PUNJAB EMPLOYEES' SOCIAL SECURITY INSTITUTION

Susp. Alu Hydroxide 215mg, Mag. Hydroxide

Tab Ranitidine. 150mg.

Inj. Ranitidine 50mg/2ml.

Cap.Omeprazole 20mg Pellets

Tab. Mag. Trisilicate 500mg + Dried Alu

Tab.Sodamint (Sodium Bicarbonate).

Inj. Atropine Sulphate 1mg/ml (1ml Amp).

Tab. / Cap. Mebevirine 135mg.

Tab. Mesalazine 400mg.

Tab.Pyridostigmine Bromide 60mg